US20140011416A1 - Three Dimensionally and Randomly Oriented Fibrous Structures - Google Patents
Three Dimensionally and Randomly Oriented Fibrous Structures Download PDFInfo
- Publication number
- US20140011416A1 US20140011416A1 US13/935,721 US201313935721A US2014011416A1 US 20140011416 A1 US20140011416 A1 US 20140011416A1 US 201313935721 A US201313935721 A US 201313935721A US 2014011416 A1 US2014011416 A1 US 2014011416A1
- Authority
- US
- United States
- Prior art keywords
- protein
- polymer
- randomly
- oriented
- fibrous structure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000835 fiber Substances 0.000 claims abstract description 95
- 238000001523 electrospinning Methods 0.000 claims abstract description 63
- 229920000642 polymer Polymers 0.000 claims abstract description 53
- 238000000034 method Methods 0.000 claims abstract description 48
- 238000009987 spinning Methods 0.000 claims abstract description 35
- 239000004094 surface-active agent Substances 0.000 claims abstract description 32
- 239000002904 solvent Substances 0.000 claims abstract description 26
- 235000018102 proteins Nutrition 0.000 claims description 68
- 102000004169 proteins and genes Human genes 0.000 claims description 68
- 108090000623 proteins and genes Proteins 0.000 claims description 68
- 229920002494 Zein Polymers 0.000 claims description 44
- 229940093612 zein Drugs 0.000 claims description 44
- 239000005019 zein Substances 0.000 claims description 44
- 239000011148 porous material Substances 0.000 claims description 32
- 239000002202 Polyethylene glycol Substances 0.000 claims description 30
- 229920001223 polyethylene glycol Polymers 0.000 claims description 30
- 241000209140 Triticum Species 0.000 claims description 29
- 235000021307 Triticum Nutrition 0.000 claims description 29
- 108010073771 Soybean Proteins Proteins 0.000 claims description 26
- 229940001941 soy protein Drugs 0.000 claims description 26
- 239000000243 solution Substances 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 21
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 18
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- 108010050792 glutenin Proteins 0.000 claims description 15
- 239000004971 Cross linker Substances 0.000 claims description 14
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 12
- 239000000872 buffer Substances 0.000 claims description 12
- 108010076876 Keratins Proteins 0.000 claims description 11
- 102000011782 Keratins Human genes 0.000 claims description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 10
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims description 10
- 239000002953 phosphate buffered saline Substances 0.000 claims description 10
- 235000021120 animal protein Nutrition 0.000 claims description 9
- 239000003945 anionic surfactant Substances 0.000 claims description 9
- 235000021118 plant-derived protein Nutrition 0.000 claims description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 8
- 108010061711 Gliadin Proteins 0.000 claims description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 8
- 108010064851 Plant Proteins Proteins 0.000 claims description 8
- 239000000701 coagulant Substances 0.000 claims description 8
- 239000002736 nonionic surfactant Substances 0.000 claims description 8
- 229920001059 synthetic polymer Polymers 0.000 claims description 8
- 230000032683 aging Effects 0.000 claims description 7
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 6
- 244000105624 Arachis hypogaea Species 0.000 claims description 6
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 6
- 235000018262 Arachis monticola Nutrition 0.000 claims description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- MKWKNSIESPFAQN-UHFFFAOYSA-N N-cyclohexyl-2-aminoethanesulfonic acid Chemical compound OS(=O)(=O)CCNC1CCCCC1 MKWKNSIESPFAQN-UHFFFAOYSA-N 0.000 claims description 6
- 239000005018 casein Substances 0.000 claims description 6
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 6
- 235000021240 caseins Nutrition 0.000 claims description 6
- 230000015271 coagulation Effects 0.000 claims description 6
- 238000005345 coagulation Methods 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 6
- 235000020232 peanut Nutrition 0.000 claims description 6
- XQQUSYWGKLRJRA-RABCQHRBSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-6-amino-2-[[(2s,3s)-2-amino-3-methylpentanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]propanoyl]amino]-3-methylbutanoic acid Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O XQQUSYWGKLRJRA-RABCQHRBSA-N 0.000 claims description 4
- IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 claims description 4
- 102000002322 Egg Proteins Human genes 0.000 claims description 4
- 108010000912 Egg Proteins Proteins 0.000 claims description 4
- 108010068370 Glutens Proteins 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- 229920000954 Polyglycolide Polymers 0.000 claims description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- 239000003093 cationic surfactant Substances 0.000 claims description 4
- 235000021312 gluten Nutrition 0.000 claims description 4
- 108010088381 isoleucyl-lysyl-valyl-alanyl-valine Proteins 0.000 claims description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 4
- 229920000520 poly(3-hydroxybutyrate-co-3-hydroxyvalerate) Polymers 0.000 claims description 4
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 claims description 4
- 229920000218 poly(hydroxyvalerate) Polymers 0.000 claims description 4
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims description 4
- 229920000070 poly-3-hydroxybutyrate Polymers 0.000 claims description 4
- 239000004633 polyglycolic acid Substances 0.000 claims description 4
- 229950008885 polyglycolic acid Drugs 0.000 claims description 4
- 229920000903 polyhydroxyalkanoate Polymers 0.000 claims description 4
- 229920002792 polyhydroxyhexanoate Polymers 0.000 claims description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 4
- 239000002888 zwitterionic surfactant Substances 0.000 claims description 4
- DGZSVBBLLGZHSF-UHFFFAOYSA-N 4,4-diethylpiperidine Chemical compound CCC1(CC)CCNCC1 DGZSVBBLLGZHSF-UHFFFAOYSA-N 0.000 claims description 3
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 3
- 102000008186 Collagen Human genes 0.000 claims description 3
- 108010035532 Collagen Proteins 0.000 claims description 3
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 3
- 239000008351 acetate buffer Substances 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 229920001436 collagen Polymers 0.000 claims description 3
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 claims description 3
- 235000011152 sodium sulphate Nutrition 0.000 claims description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- 150000003923 2,5-pyrrolediones Chemical class 0.000 claims description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims description 2
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 claims description 2
- 235000006008 Brassica napus var napus Nutrition 0.000 claims description 2
- 240000000385 Brassica napus var. napus Species 0.000 claims description 2
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 claims description 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims description 2
- 235000016401 Camelina Nutrition 0.000 claims description 2
- 244000197813 Camelina sativa Species 0.000 claims description 2
- 241000207199 Citrus Species 0.000 claims description 2
- 102000009123 Fibrin Human genes 0.000 claims description 2
- 108010073385 Fibrin Proteins 0.000 claims description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims description 2
- 241000287828 Gallus gallus Species 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 241000408747 Lepomis gibbosus Species 0.000 claims description 2
- 240000007594 Oryza sativa Species 0.000 claims description 2
- 235000007164 Oryza sativa Nutrition 0.000 claims description 2
- 108010084695 Pea Proteins Proteins 0.000 claims description 2
- 240000004713 Pisum sativum Species 0.000 claims description 2
- 235000016816 Pisum sativum subsp sativum Nutrition 0.000 claims description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 2
- 240000006394 Sorghum bicolor Species 0.000 claims description 2
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 2
- 244000062793 Sorghum vulgare Species 0.000 claims description 2
- 240000001417 Vigna umbellata Species 0.000 claims description 2
- 235000011453 Vigna umbellata Nutrition 0.000 claims description 2
- 108010046377 Whey Proteins Proteins 0.000 claims description 2
- 102000007544 Whey Proteins Human genes 0.000 claims description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 claims description 2
- 108010072041 arginyl-glycyl-aspartic acid Proteins 0.000 claims description 2
- 150000001718 carbodiimides Chemical class 0.000 claims description 2
- 125000002843 carboxylic acid group Chemical group 0.000 claims description 2
- 235000019705 chickpea protein Nutrition 0.000 claims description 2
- 235000020971 citrus fruits Nutrition 0.000 claims description 2
- 235000014103 egg white Nutrition 0.000 claims description 2
- 210000000969 egg white Anatomy 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 210000003746 feather Anatomy 0.000 claims description 2
- 229950003499 fibrin Drugs 0.000 claims description 2
- 235000019253 formic acid Nutrition 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 210000004209 hair Anatomy 0.000 claims description 2
- 239000012948 isocyanate Substances 0.000 claims description 2
- 150000002513 isocyanates Chemical class 0.000 claims description 2
- 235000019713 millet Nutrition 0.000 claims description 2
- 235000019707 mung bean protein Nutrition 0.000 claims description 2
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 claims description 2
- 239000004626 polylactic acid Substances 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 235000020236 pumpkin seed Nutrition 0.000 claims description 2
- 235000009566 rice Nutrition 0.000 claims description 2
- -1 silk Proteins 0.000 claims description 2
- 235000020238 sunflower seed Nutrition 0.000 claims description 2
- 150000003505 terpenes Chemical class 0.000 claims description 2
- 235000007586 terpenes Nutrition 0.000 claims description 2
- 235000021119 whey protein Nutrition 0.000 claims description 2
- 210000002268 wool Anatomy 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 description 46
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 28
- 235000018417 cysteine Nutrition 0.000 description 14
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 14
- 239000000463 material Substances 0.000 description 13
- KPKZJLCSROULON-QKGLWVMZSA-N Phalloidin Chemical compound N1C(=O)[C@@H]([C@@H](O)C)NC(=O)[C@H](C)NC(=O)[C@H](C[C@@](C)(O)CO)NC(=O)[C@H](C2)NC(=O)[C@H](C)NC(=O)[C@@H]3C[C@H](O)CN3C(=O)[C@@H]1CSC1=C2C2=CC=CC=C2N1 KPKZJLCSROULON-QKGLWVMZSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 238000001125 extrusion Methods 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- 230000035755 proliferation Effects 0.000 description 9
- 210000002744 extracellular matrix Anatomy 0.000 description 8
- 230000003247 decreasing effect Effects 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 108010009711 Phalloidine Proteins 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 238000001218 confocal laser scanning microscopy Methods 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000003638 chemical reducing agent Substances 0.000 description 5
- 230000008021 deposition Effects 0.000 description 5
- 230000035515 penetration Effects 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 101710200191 Feather keratin Proteins 0.000 description 4
- 229920001410 Microfiber Polymers 0.000 description 4
- 238000004132 cross linking Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 239000012212 insulator Substances 0.000 description 4
- 238000010899 nucleation Methods 0.000 description 4
- 150000003573 thiols Chemical class 0.000 description 4
- 102000007469 Actins Human genes 0.000 description 3
- 108010085238 Actins Proteins 0.000 description 3
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- 229960000686 benzalkonium chloride Drugs 0.000 description 3
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 230000005611 electricity Effects 0.000 description 3
- FHBSGPWHCCIQPG-UHFFFAOYSA-N hydroxy-methyl-oxo-sulfanylidene-$l^{6}-sulfane Chemical compound CS(S)(=O)=O FHBSGPWHCCIQPG-UHFFFAOYSA-N 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 229940083575 sodium dodecyl sulfate Drugs 0.000 description 3
- 230000007480 spreading Effects 0.000 description 3
- 238000003892 spreading Methods 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- 239000002352 surface water Substances 0.000 description 3
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 3
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 2
- RLHGFJMGWQXPBW-UHFFFAOYSA-N 2-hydroxy-3-(1h-imidazol-5-ylmethyl)benzamide Chemical compound NC(=O)C1=CC=CC(CC=2NC=NC=2)=C1O RLHGFJMGWQXPBW-UHFFFAOYSA-N 0.000 description 2
- UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 description 2
- GUQQBLRVXOUDTN-XOHPMCGNSA-N 3-[dimethyl-[3-[[(4r)-4-[(3r,5s,7r,8r,9s,10s,12s,13r,14s,17r)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CC(O)CS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 GUQQBLRVXOUDTN-XOHPMCGNSA-N 0.000 description 2
- 239000012112 Alexa Fluor 633 Substances 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- 238000000719 MTS assay Methods 0.000 description 2
- 231100000070 MTS assay Toxicity 0.000 description 2
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 2
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 2
- 238000005299 abrasion Methods 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- QMKYBPDZANOJGF-UHFFFAOYSA-N benzene-1,3,5-tricarboxylic acid Chemical compound OC(=O)C1=CC(C(O)=O)=CC(C(O)=O)=C1 QMKYBPDZANOJGF-UHFFFAOYSA-N 0.000 description 2
- 229960001950 benzethonium chloride Drugs 0.000 description 2
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 2
- 235000011089 carbon dioxide Nutrition 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 229960000800 cetrimonium bromide Drugs 0.000 description 2
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 2
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 2
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 2
- 238000005137 deposition process Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- PSLWZOIUBRXAQW-UHFFFAOYSA-M dimethyl(dioctadecyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC PSLWZOIUBRXAQW-UHFFFAOYSA-M 0.000 description 2
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- YDSWCNNOKPMOTP-UHFFFAOYSA-N mellitic acid Chemical compound OC(=O)C1=C(C(O)=O)C(C(O)=O)=C(C(O)=O)C(C(O)=O)=C1C(O)=O YDSWCNNOKPMOTP-UHFFFAOYSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- SUVIGLJNEAMWEG-UHFFFAOYSA-N propane-1-thiol Chemical compound CCCS SUVIGLJNEAMWEG-UHFFFAOYSA-N 0.000 description 2
- KJRCEJOSASVSRA-UHFFFAOYSA-N propane-2-thiol Chemical compound CC(C)S KJRCEJOSASVSRA-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- WGTYBPLFGIVFAS-UHFFFAOYSA-M tetramethylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)C WGTYBPLFGIVFAS-UHFFFAOYSA-M 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- KQTIIICEAUMSDG-UHFFFAOYSA-N tricarballylic acid Chemical compound OC(=O)CC(C(O)=O)CC(O)=O KQTIIICEAUMSDG-UHFFFAOYSA-N 0.000 description 2
- 238000002166 wet spinning Methods 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- 239000001124 (E)-prop-1-ene-1,2,3-tricarboxylic acid Substances 0.000 description 1
- ZRKMQKLGEQPLNS-UHFFFAOYSA-N 1-Pentanethiol Chemical class CCCCCS ZRKMQKLGEQPLNS-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FVRYCPZDHKLBNR-UHFFFAOYSA-N 2-mercaptoindole Chemical compound C1=CC=C2NC(S)=CC2=C1 FVRYCPZDHKLBNR-UHFFFAOYSA-N 0.000 description 1
- DUIOKRXOKLLURE-UHFFFAOYSA-N 2-octylphenol Chemical compound CCCCCCCCC1=CC=CC=C1O DUIOKRXOKLLURE-UHFFFAOYSA-N 0.000 description 1
- IXOCGRPBILEGOX-UHFFFAOYSA-N 3-[3-(dodecanoylamino)propyl-dimethylazaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)CS([O-])(=O)=O IXOCGRPBILEGOX-UHFFFAOYSA-N 0.000 description 1
- CDOUZKKFHVEKRI-UHFFFAOYSA-N 3-bromo-n-[(prop-2-enoylamino)methyl]propanamide Chemical compound BrCCC(=O)NCNC(=O)C=C CDOUZKKFHVEKRI-UHFFFAOYSA-N 0.000 description 1
- APRZHQXAAWPYHS-UHFFFAOYSA-N 4-[5-[3-(carboxymethoxy)phenyl]-3-(4,5-dimethyl-1,3-thiazol-2-yl)tetrazol-3-ium-2-yl]benzenesulfonate Chemical compound S1C(C)=C(C)N=C1[N+]1=NC(C=2C=C(OCC(O)=O)C=CC=2)=NN1C1=CC=C(S([O-])(=O)=O)C=C1 APRZHQXAAWPYHS-UHFFFAOYSA-N 0.000 description 1
- 229940046305 5-bromo-5-nitro-1,3-dioxane Drugs 0.000 description 1
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
- ODBLHEXUDAPZAU-ZAFYKAAXSA-N D-threo-isocitric acid Chemical compound OC(=O)[C@H](O)[C@@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-ZAFYKAAXSA-N 0.000 description 1
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ODBLHEXUDAPZAU-FONMRSAGSA-N Isocitric acid Natural products OC(=O)[C@@H](O)[C@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-FONMRSAGSA-N 0.000 description 1
- 239000007832 Na2SO4 Substances 0.000 description 1
- 235000001188 Peltandra virginica Nutrition 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 102000002067 Protein Subunits Human genes 0.000 description 1
- 108010001267 Protein Subunits Proteins 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 108010055615 Zein Proteins 0.000 description 1
- HIPVJRPEJALNIE-UHFFFAOYSA-L [Na+].[K+].OS([O-])=O.OS([O-])=O Chemical compound [Na+].[K+].OS([O-])=O.OS([O-])=O HIPVJRPEJALNIE-UHFFFAOYSA-L 0.000 description 1
- 229940091181 aconitic acid Drugs 0.000 description 1
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 description 1
- 229940063953 ammonium lauryl sulfate Drugs 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- XVBRCOKDZVQYAY-UHFFFAOYSA-N bronidox Chemical compound [O-][N+](=O)C1(Br)COCOC1 XVBRCOKDZVQYAY-UHFFFAOYSA-N 0.000 description 1
- WQAQPCDUOCURKW-UHFFFAOYSA-N butanethiol Chemical compound CCCCS WQAQPCDUOCURKW-UHFFFAOYSA-N 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000001516 cell proliferation assay Methods 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- GTZCVFVGUGFEME-IWQZZHSRSA-N cis-aconitic acid Chemical compound OC(=O)C\C(C(O)=O)=C\C(O)=O GTZCVFVGUGFEME-IWQZZHSRSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
- 239000005516 coenzyme A Substances 0.000 description 1
- 229940093530 coenzyme a Drugs 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 229940073499 decyl glucoside Drugs 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000012606 in vitro cell culture Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- PJUIMOJAAPLTRJ-UHFFFAOYSA-N monothioglycerol Chemical compound OCC(O)CS PJUIMOJAAPLTRJ-UHFFFAOYSA-N 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- SMGTYJPMKXNQFY-UHFFFAOYSA-N octenidine dihydrochloride Chemical compound Cl.Cl.C1=CC(=NCCCCCCCC)C=CN1CCCCCCCCCCN1C=CC(=NCCCCCCCC)C=C1 SMGTYJPMKXNQFY-UHFFFAOYSA-N 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000007903 penetration ability Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 239000003361 porogen Substances 0.000 description 1
- DJEHXEMURTVAOE-UHFFFAOYSA-M potassium bisulfite Chemical compound [K+].OS([O-])=O DJEHXEMURTVAOE-UHFFFAOYSA-M 0.000 description 1
- 229940099427 potassium bisulfite Drugs 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 235000010259 potassium hydrogen sulphite Nutrition 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 description 1
- 229940043349 potassium metabisulfite Drugs 0.000 description 1
- 235000010263 potassium metabisulphite Nutrition 0.000 description 1
- DPLVEEXVKBWGHE-UHFFFAOYSA-N potassium sulfide Chemical compound [S-2].[K+].[K+] DPLVEEXVKBWGHE-UHFFFAOYSA-N 0.000 description 1
- 229940068479 potassium sulfide Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108060006613 prolamin Proteins 0.000 description 1
- KOUKXHPPRFNWPP-UHFFFAOYSA-N pyrazine-2,5-dicarboxylic acid;hydrate Chemical compound O.OC(=O)C1=CN=C(C(O)=O)C=N1 KOUKXHPPRFNWPP-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940001607 sodium bisulfite Drugs 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 229940057950 sodium laureth sulfate Drugs 0.000 description 1
- 229940079862 sodium lauryl sarcosinate Drugs 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- MDSQKJDNWUMBQQ-UHFFFAOYSA-M sodium myreth sulfate Chemical compound [Na+].CCCCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O MDSQKJDNWUMBQQ-UHFFFAOYSA-M 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- 229940079101 sodium sulfide Drugs 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 1
- ADWNFGORSPBALY-UHFFFAOYSA-M sodium;2-[dodecyl(methyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCN(C)CC([O-])=O ADWNFGORSPBALY-UHFFFAOYSA-M 0.000 description 1
- 229940071440 soy protein isolate Drugs 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical class [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- WMXCDAVJEZZYLT-UHFFFAOYSA-N tert-butylthiol Chemical compound CC(C)(C)S WMXCDAVJEZZYLT-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- AYEKOFBPNLCAJY-UHFFFAOYSA-O thiamine pyrophosphate Chemical compound CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N AYEKOFBPNLCAJY-UHFFFAOYSA-O 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- ODBLHEXUDAPZAU-UHFFFAOYSA-N threo-D-isocitric acid Natural products OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- GTZCVFVGUGFEME-UHFFFAOYSA-N trans-aconitic acid Natural products OC(=O)CC(C(O)=O)=CC(O)=O GTZCVFVGUGFEME-UHFFFAOYSA-N 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 229920003170 water-soluble synthetic polymer Polymers 0.000 description 1
Images
Classifications
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0015—Electro-spinning characterised by the initial state of the material
- D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F1/00—General methods for the manufacture of artificial filaments or the like
- D01F1/02—Addition of substances to the spinning solution or to the melt
- D01F1/10—Other agents for modifying properties
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
- D04H1/70—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres
- D04H1/72—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged
- D04H1/728—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged by electro-spinning
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T442/00—Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
- Y10T442/60—Nonwoven fabric [i.e., nonwoven strand or fiber material]
- Y10T442/608—Including strand or fiber material which is of specific structural definition
Definitions
- This invention is directed to electrospinning three-dimensionally (3D) and randomly oriented fibrous structures from various polymer sources, including plant proteins, animal proteins, and synthetic polymers.
- Ideal tissue engineering scaffolds should be capable of closely mimicking the topographies and spatial structures of native extracellular matrices (ECMs) to facilitate cells to grow and differentiate following the patterns similar to that found in native tissues and organs.
- ECMs extracellular matrices
- Morphologies of ECMs vary according to functions of target tissues and cell types in the tissues.
- the top layer is formed by compact packing of epithelial cells on a two-dimensional (2D) fibrous ECM basement membrane.
- Three-dimensional spatial spreading of fibroblasts and immune cells occurs in the interior region of the skin tissue, and correspondingly the ECMs are constructed by stereoscopically and randomly oriented ultrafine protein fibers.
- Fibrous structures with 3D orientation and random distribution can also be found in native ECMs in breast, liver, bladder, lung, and many other organs and tissues. It has been reported that cells cultured on flat 2D substrates may differ considerably in morphology and differentiation pattern from those cultured in more physiological 3D environments. Therefore, it is reasonable to fabricate scaffolds with particular morphologies and structures according to categories and functions of original native tissues.
- tissue engineering scaffolds composed of nano- or submicrometer-fibers from numerous materials.
- conventional electrospun structures typically form 2D scaffolds with fibers aligned parallel to the collector and cells cultured on the conventional electrospun scaffolds could only develop into flat shapes. The functions and differentiation of many flattened cells could not resemble the native stereoscopic cells.
- small pore sizes owing to the close arrangement of fibers, restricted access of cells to the interior of conventional electrospun scaffolds.
- cells could mainly spread and distribute within a shallow depth beneath the surface.
- the parallel fibrous layer-by-layer structures tended to not have pores that extend very far in the thickness direction as compared to in the planar directions.
- there was limited improvement in scaffold porosity and cells cultured thereon tended to have flattened morphologies rather than stereoscopically developed cells in many native tissues.
- the present invention is directed to a method of making a randomly-oriented 3-D fibrous structure.
- the method comprising electrospinning a spinning dope with an electrospinning apparatus, wherein the spinning dope comprises: a solvent; a polymer dissolved in the solvent, wherein the dissolved polymer is in subunits having molecular weights that are about 5 to about 150 kDa; and a surfactant; to form one or more fibers that comprise a polymer-surfactant complex and that arrange randomly and evenly in three dimensions when contacting a collecting board of the electrospinning apparatus thereby forming the randomly-oriented 3-D fibrous structure.
- the present invention is directed to a method of making a randomly-oriented 3-D fibrous structure.
- the method comprising electrospinning a spinning dope with an electrospinning apparatus, wherein the spinning dope comprises: a solvent; a polymer dissolved in the solvent, wherein the dissolved polymer is in subunits having molecular weights that are about 5 to about 150 kDa, and wherein the polymer is selected from the group consisting of protein, synthetic polymer, and combinations thereof; and an anionic surfactant at about 5 to about 300 percent by weight of the polymer; to form one or more fibers of a fineness that is about 50 nm to about 100 ⁇ m and that comprise a polymer-surfactant complex and that arrange randomly and evenly in three dimensions when contacting a collecting board of the electrospinning apparatus thereby forming the randomly-oriented 3-D fibrous structure that further comprises interconnected pores having sizes that are about 10 to 2000 ⁇ m and that has a porosity that is about 60 to about 99.9% by volume.
- the present invention is directed to a randomly-oriented 3-D fibrous structure comprising: one or more fibers that comprise a polymer-surfactant complex, wherein the fiber(s) have lengths that are at least about 100 nm and finenesses that are about 50 nm to about 100 ⁇ m, and are arranged randomly and evenly in three dimensions throughout the randomly-oriented 3-D fibrous structure; and interconnected pores having sizes that are about 10 to 2,000 ⁇ m, wherein the pores comprise about 60 to about 99.9% by volume of the randomly-oriented 3-D fibrous structure.
- FIG. 1 contains schematic diagrams of fibers being deposited via electrospinning in which the 2D column contains images (a), (b), and (c) showing the parallel deposition of conventional electrospun fibers and the 3D column contains images (d), (e), and (f) showing the deposition of fibers according to the present invention.
- FIG. 2 contains photographic images of fibers being deposited via electrospinning in which the (a) column contains images 1, 2, and 3, which were taken at 0.125 second intervals showing the deposition of conventional, parallel-aligned electrospun fibers and the (b) column contains images 1, 2, and 3, which were taken at 0.125 second intervals showing the vertical deposition of fibers according to the present invention.
- FIG. 3 is a photographic comparison of a zein electrospun randomly-oriented 3-D fibrous structure and a zein electrospun 2D fibrous structure; the structures are of the same weight.
- FIG. 4 are images of a zein electrospun randomly-oriented 3-D fibrous structure: (a) is a SEM 70x top view image; (b) is a SEM 70x side view image; (c) is a CLSM 100x 45 degree front view image; and (d) is a CLSM 100x side view image.
- FIG. 5 are CLSM 60x images of sequential sections of 2D [(a) 1, 2, 3, and 4] and randomly-oriented 3-D fibrous structures [(b) 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12] each taken at increasing 10 ⁇ m depths in which the lighter network is F-actin in NIH 3T3 cells stained with Phalloidin 633 after being cultured in the structures for 72 hours.
- FIG. 6 is graph of MTS assay results of attachment (4 hours) and proliferation (24, 72, 120, and 168 hours) of NIH 3T3 fibroblase cells on 2D and 3D zein electrospun fibrous structures.
- FIG. 7 are CLSM images showing the proliferation of NIH 3T3 cells on 2D and 3D zein electrospun fibrous structures about 48 hours after seeding (stained with Phalloidin 633 and Hoechst 33342).
- the three-dimensional reconstruction of the 2D fibrous structure is (a): x-y projection (I); x-z projection (II′); and y-z projection (III).
- the three-dimensional reconstruction of the 3D fibrous structures is (b): x-y projection (I′); x-z projection (II′); and y-z projection (III′).
- FIG. 8 is a photographic comparison of an electrospun randomly-oriented 3-D PEG fibrous structure prepared with SDS and an electrospun 2D fibrous structure; the structures are of the same weight.
- FIG. 9 is a photograph of a PEG electrospun randomly-oriented 3-D fibrous structure prepared with a nonionic surfactant.
- FIG. 10 is a SDS-PAGE of soy protein, and wheat glutenin, wherein lane 1 shows standard protein markers, lane 2 is untreated soy protein, lane 3 is cysteine extracted soy protein, lane 4 is NaOH extracted soy protein, lane 5 is untreated wheat glutenin, and lane 6 is cysteine extracted wheat glutenin.
- FIG. 11 is a photograph of a soy protein electrospun randomly-oriented 3-D fibrous structure.
- FIG. 12 is are photographs of soy protein electrospun randomly-oriented 3-D fibrous structure, wherein (a) is before immersion in PBS and (b) is 3 days after immersion in PBS; scale bar is 20 ⁇ m.
- FIG. 13 is a photograph of a feather keratin electrospun randomly-oriented 3-D fibrous structure.
- FIG. 14 is a photograph of a wheat glutenin electrospun randomly-oriented 3-D fibrous structure.
- FIG. 15 is a photograph of a wheat gliadin electrospun randomly-oriented 3-D fibrous structure.
- FIG. 16 is a photograph of a casein electrospun randomly-oriented 3-D fibrous structure.
- FIG. 17 is photograph of a peanut electrospun randomly-oriented 3-D fibrous structure.
- FIG. 18 ( a ) is graph showing the relationship between specific pore volume of electrospun scaffolds and surface resistivity (the dashed line shows the simulated relation using power function) and FIG. 18 ( b ) is a graph showing the effect of sodium dodecyl sulfate (SDS) and NaCl on surface resistivity of PEG films based on the proportions of SDS to polymer (the molar concentration of NaCl was the same as that of SDS at each point).
- SDS sodium dodecyl sulfate
- FIG. 19 ( a ) are photographs of the deposition process of zein onto an insulator covered collector at time intervals of 0.125 seconds between each image (the spinning dope consisted of 25 wt % zein and 25 wt % SDS);
- FIG. 19 ( b ) is a photograph of the as-spun zein scaffold;
- FIG. 19( c ) is a CLSM 45° image at magnification of 100 ⁇ of the above as-spun zein scaffold.
- An embodiment of the present invention is directed to a method of making a randomly-oriented 3-D fibrous structure.
- the method comprising electrospinning a spinning dope with an electrospinning apparatus, wherein the spinning dope comprises: a solvent; a polymer dissolved in the solvent, wherein the dissolved polymer is in subunits having molecular weights that are about 5 to about 150 kDa; and a surfactant; to form one or more fibers that comprise a polymer-surfactant complex and that arrange randomly and evenly in three dimensions when contacting a collecting board of the electrospinning apparatus thereby forming the randomly-oriented 3-D fibrous structure.
- the electrospinning is conducted at a temperature that is about 25 to about 70° C.
- the “randomly-oriented 3-D fibrous structure” is intended to mean fibrous structure in which the one or more fibers thereof are randomly oriented in all three dimensions rather than only being randomly oriented in two dimensions as can be found in conventional layer-by-layer, planar structures.
- the degree of random orientation of a fibrous structure may be quantified by, for example, identifying a cubic centimeter volume of said fibrous structure and identifying any particular imaginary plane of any orientation within said volume, identifying the number of fibers intersected or fiber intersections both of which are “intersections” with said plane, and identifying the number of said intersections in which said intersected fiber(s) are at angles greater than 30 degrees relative to said plane.
- at least 1 ⁇ 2, 5 ⁇ 8, 2 ⁇ 3, and 3 ⁇ 4 of the intersected fibers are at angles greater than 30 degrees with the plane.
- FIG. 1 the mechanisms of 2D electrospinning and an embodiment of 3D electrospinning (of the present invention produce) are depicted in FIG. 1 .
- the liquid droplet acquired negative charges and then was elongated into fibers.
- relatively few of the electrons are transferred to the collector at the moment the fiber ends hit the collector, owing to high surface resistivity of the fibers.
- the fibers with a relatively large amount of remaining electrons are strongly attracted to the positively charged collector.
- conventional 2D electrospun scaffolds have fibers oriented parallel to the collecting board and the fibrous structures are relatively tightly packed.
- the depicted 3D electrospinning embodiment is believed to be based on repulsive electrical force between fibers and the collector. More specifically, the method of the present invention, involves including a surfactant to decrease the surface resistivity of a fiber to thereby increase the transfer of charge from the fiber surface to the collector.
- a surfactant to decrease the surface resistivity of a fiber to thereby increase the transfer of charge from the fiber surface to the collector.
- surface static electricity transfers to the board in a faster manner, which results in less negative static electricity remaining on the fiber(s), and decreased attraction between fiber(s) and the collector.
- the near portion of the fibers may even carry positive charges and may be repulsed by the collector, while the farther end of the fiber(s) is still attracted and moves towards the board.
- fiber(s) are collected onto the board in multiple orientations to form loose and fluffy 3D scaffolds with randomly-oriented fiber(s).
- FIG. 2 is conventional electrospinning and FIG. 2 b is electrospinning in accordance with the present invention at 0.125 second intervals between sequential photographs with the the white objects PEG fibrous bulks.
- the spinning dope comprises a polymer, which may be any appropriate polymer such as protein, synthetic polymer, and combinations thereof.
- Proteins may be of particular interest because they are preferred in biomedical applications due to their molecular similarity to native ECMs, and tend to be widely available at low cost.
- plant proteins, zein and soy protein, and animal proteins, such as keratin and collagen have been proved to be supportive to cell growth in in vitro and in vivo studies.
- plant and animal proteins are widely available at a low cost and they are considered to be a renewable resource.
- the method of the present invention may be conducted using one or more proteins selected from the group consisting of plant protein, animal protein, and combinations thereof.
- proteins with cysteine content higher than 1% in its amino acid composition are considered to be highly-crosslinked proteins.
- electrospinning highly crosslinked proteins, such as soy protein, feather keratin and wheat glutenin, into fibrous structures via electrospinning has not been possible due to their insolubility in various solvents.
- the present invention of electrospinning may be practiced, however, with highly crosslinked protein by dissolving the protein in manner that preserves the protein subunits with appropriate molecular weights ranging from 5 to 150 kDa.
- Other methods of dissolving highly crosslinked proteins e.g., U.S. Pat. Pub. No. 2006/0282958, Yang et al., entitled Process for the Production of High Quality Fibers from Wheat Proteins and Products Made From Wheat Proteins ) allowed for the spinning of coarse fibers but were not suitable for electrospinning of relatively fine fibers.
- the electrospinning method of the present invention may be practiced with highly crosslinked proteins by using a reducing agent such a thiol, a sulfite, or a sulfide to break the disulfide bonds of the highly crosslinked proteins.
- a reducing agent such as a thiol, a sulfite, or a sulfide
- cysteine an environmentally-benign thiol
- the amount of the reducing agent in the solution may be varied from about 1% to about 50% based on the weight of proteins.
- the solvent for the protein and cysteine was a 4-8 M urea solution with pH of 8 to 12, adjusted using 50 wt % sodium hydroxide solution.
- the weight ratio of protein-containing materials to urea solution may be varied within a range from, for example, 1:5 to 1:30.
- the temperature for the dissolution may be within a range from about 20° C. to about 90° C.
- additional appropriate thiols include methanethiol, ethanethiol, 1-propanethiol, 2-propanethiol, butanethiol, tert-butyl mercaptan, pentanethiols, thiophenol, thioacetic acid, coenzyme-A, glutathione, 2-mercaptoethanol, dithiothreitol, 2-mercaptoindole, 3-mercaptopropane-1,2-diol.
- Examples of appropriate sulfites and sulfides include sodium sulfite potassium sulfite, sodium bisulfite, potassium bisulfite, sodium sulfide, potassium sulfide, sodium metabisulfite, and potassium metabisulfite.
- the conditions for the reactions include the thiol/sulfite/sulfide at concentration(s) of about 0.5% to about 50% based on the weight of proteins, a pH from 3 to 12 for a duration of about 30 minutes to about 24 hours at a temperature of about 20° C. to about 90° C.
- the method of the present invention may, in certain embodiments, be conducted using appropriately dissolved highly-crosslinked plant protein, highly-crosslinked animal protein, and combinations thereof.
- proteins including highly-crosslinked proteins
- experimental results to date have shown the aging the dissolved protein at an aging temperature that is about 20° C. to about 90° C. for an aging duration that is about 0.5 to about 48 hours before conducting the electrospinning may be advantageous.
- it has been found that such aging may provide a higher degree of disentanglement of the protein molecules to improve the spinnability of the protein spinning dope.
- Exemplary plant proteins include wheat gluten, wheat gliadin, wheat glutenin, soy protein, camelina protein, peanut protein, canola protein, sorghum protein, rice protein, millet protein, sunflower seed protein, pumpkin seed protein, mung bean protein, red bean protein, chickpea protein, green pea protein, and combinations thereof;
- Exemplary animal proteins include chicken feather, egg white, wool keratin, casein, silk, fibrin, collagen, gelatin, hair keratin, horn keratin, nail keratin, whey protein, and combinations thereof.
- Exemplary synthetic polymers include polyethylene glycol (PEG), poly lactic acid (PLA), poly glycolic acid (PGA), polyhydroxyalkanoates (PHAs), poly(lactic-co-glycolic acid) (PLGA), poly-3-hydroxybutyrate (PHB), polyhydroxyvalerate (PHV), polyhydroxyhexanoate (PHH), poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV), and combinations thereof.
- PEG polyethylene glycol
- PLA poly lactic acid
- PGA poly glycolic acid
- PHAs polyhydroxyalkanoates
- PGA poly(lactic-co-glycolic acid)
- PBB poly-3-hydroxybutyrate
- PV polyhydroxyvalerate
- PH polyhydroxyhexanoate
- PHBV poly(3-hydroxybutyrate-co-3-hydroxyvalerate)
- the solution may comprise one, two, or even more polymers.
- the polymer that is in the largest amount (usually more than half of the total polymer content) is often referred to as the “primary” polymer, component, or material and the additional polymers are often referred to as “secondary” polymer(s), component(s), or material(s) with concentrations that are from about 0.5% to about 50% by weight of the primary polymer.
- the spinning dope comprises a surfactant, which may be any appropriate surfactant.
- the hydrophobic portions of surfactant bond with polymers through hydrophobic interaction to form a protein-surfactant complex.
- the hydrophilic portions including functional groups that carry positive or negative charges and polar uncharged groups, gather on the fiber surface and thus effectively increase the surface conductivity (or lower the surface resistivity) by introducing surface water layer, which facilitates delivery of charges on the surface.
- the surfactant(s) may be of different hydrocarbon chain lengths and different electrical properties, including anionic surfactants, cationic surfactants, nonionic surfactants, zwitterionic surfactants. In an embodiment, combinations of surfactants may be used, as appropriate. In another embodiment, the surfactant is one or more anionic surfactants.
- the spinning dope has a concentration of the surfactant that is about 5 to about 300 percent by weight of the polymer. In another embodiment, the spinning dope has a concentration of the surfactant that is about 50 to about 150 percent by weight of the polymer.
- Exemplary anionic surfactants include sodium dodecyl sulfate, sodium dodecyl benzenesulfonate, sodium lauryl sarcosinate, perflourobutanesulfonic acid, ammonium lauryl sulfate, sodium stearate, sodium pareth sulfate, dioctyl sodium sulfosuccinate, potassium lauryl sulfate, sodium laureth sulfate, sodium myreth sulfate, and combinations thereof.
- Exemplary cationic surfactants include benzalkonium chloride, cetrimonium bromide, tetramethylammonium hydroxide, octenidine dihydrochloride cetyl trimethylammonium bromide, hexadecyl trimethyl ammonium bromide, cetyl trimethylammonium chloride (CTAC), cetylpyridinium chloride (CPC), benzalkonium chloride (BAC), benzethonium chloride (BZT), 5-bromo-5-nitro-1,3-dioxane, dimethyldioctadecylammonium chloride, cetrimonium bromide, dioctadecyldimethylammonium bromide (DODAB), and combinations thereof.
- benzalkonium chloride cetrimonium bromide, tetramethylammonium hydroxide, octenidine dihydrochloride cetyl trimethylammonium bromide, hexadec
- nonionic surfactants include decyl glucoside, octyl phenol ethoxylated, polysorbate 80, polysorbate 20, and combinations thereof.
- Exemplary zwitterionic surfactants include cocamidopropyl hydroxysultaine, cocamidopropyl betaine, lecithin, 3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS), 3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonate (CHAPSO), and combinations thereof.
- the spinning dope comprises a solvent, which may be any appropriate solvent.
- solvents include water, phosphate buffered saline (PBS), carbonate buffer, tris-glycine buffer, borate buffer, acetate buffer, n-cyclohexyl-2-aminoethanesulfonic acid (CHES) buffer, citric buffer, ethanol, chloroform, 1,4-dioxane, methanol, ethylene glycol, acetone, ethyl acetate, methyl acetate, hexane, petrol ether, citrus terpenes, diethyl ether, dichloromethane, dimethylformamide (DMF), acetonitrile (MeCN), dimethyl sulfoxide (DMSO), formic acid, n-butanol, isopropanol (IPA), n-propanol, acetic acid, nitromethane, dichloromethane, and combinations thereof.
- PBS phosphate buffere
- the solvent is selected from the group consisting of water, phosphate buffered saline (PBS), carbonate buffer, tris-glycine buffer, borate buffer, acetate buffer, n-cyclohexyl-2-aminoethanesulfonic acid (CHES) buffer, citric buffer, chloroform, and combinations thereof.
- PBS phosphate buffered saline
- CHES n-cyclohexyl-2-aminoethanesulfonic acid
- the spinning dope may comprise one or more additional components such as a cross-linker, a sacrificial component, or a combination thereof.
- the method may further comprise contacting the fibers with a second solution that comprises a second cross-linker, a surface decorator, or a combination thereof.
- Exemplary cross-linkers include polycarboxylic acid which contains at least three carboxylic acid groups (such as citric acid, iso-citric acid, propane-1,2,3-tricarboxylic acid, trimesic acid, aconitic acid, mellitic acid, 1,2,3,4-Butane tetracarboxylic acid (BTCA)), oxysucrose, genepin, glutaraldehyde, oxaldehyde, NHS esters, maleimides, carbodiimide, isocyanate, and combinations thereof.
- the concentration of cross-linker is typically about 0.01 mol/L to about 10 mol/L.
- the spinning dope comprises a first cross-linker and the method further comprises contacting the fibers with a cross-linking solution that comprises a second cross-linker
- the first and second cross-linkers may be independently selected and as such may be identical or different (e.g., in terms of material, concentration, or both).
- the first and second cross-linkers are independently selected from the group consisting citric acid, 1,2,3,4-Butane tetracarboxylic acid (BTCA), oxysucrose, genepin, glutaraldehyde, oxaldehyde, and combinations thereof.
- Exemplary sacrificial components include PEG, egg white protein, zein, wheat gliadin, and other materials that may be dissolved with the above-described polymer(s) before electrospinning at concentrations of about 0.5% to about 50% based on the weight of the polymer.
- the sacrificial component(s) may be removed from the spun fibrous structure via rinsing with water, organic solvents or alcoholic solvents.
- Exemplary surface decorators of fibers include peptides such as Arg-Gly-Asp (RGD), Ile-Lys-Val-Ala-Val (IKVAV), Asn-Ser-Gly-Ala-Ile-Thr-Ile-Gly (NSGAITIG), and combinations thereof at concentrations of about 0.5% to about 10% based on the weight of the polymer.
- peptides such as Arg-Gly-Asp (RGD), Ile-Lys-Val-Ala-Val (IKVAV), Asn-Ser-Gly-Ala-Ile-Thr-Ile-Gly (NSGAITIG), and combinations thereof at concentrations of about 0.5% to about 10% based on the weight of the polymer.
- the method may further comprise contacting the fibers with a coagulation solution that comprises a coagulant to modify the water stability and mechanical properties of the fibers (e.g., tensile properties, compressive properties, abrasion properties, and bending properties).
- exemplary coagulants include methanol, ethanol, sodium sulfate and acetic acid, acetone, sulfuric acid, hydrochloric acid, and combinations thereof.
- the coagulant is selected from the group consisting of methanol, ethanol, sodium sulfate and acetic acid, and combinations thereof.
- the amount of coagulant in the coagulant solution is such that the concentration of coagulant is typically about 1% to about 100%.
- the fibers are contacted with the coagulation solution for a duration of about 5 minutes to about 24 hours.
- the coagulation solution is typically at a temperature that is from about 20° C. to about 100° C.
- Such a fibrous structure comprises: one or more fibers that comprise a polymer-surfactant complex, wherein the fiber(s) have lengths that are at least about 100 nm and finenesses that are about 50 nm to about 100 ⁇ m, and are arranged randomly and evenly in three dimensions throughout the randomly-oriented 3-D fibrous structure; and interconnected pores having sizes that are about 10 to 2,000 ⁇ m, wherein the pores comprise about 60 to about 99.9% by volume of the randomly-oriented 3-D fibrous structure.
- experimental results to date indicated that such randomly-oriented, three-dimensionally fibrous structures may be used to facilitate cells to grow and spread in three dimensions in a manner similar to that seen in native ECMs.
- the fibers have a fineness that is about 50 nm to about 100 ⁇ m and the randomly-oriented 3-D fibrous structure further comprises interconnected pores having sizes that are about 10 to 2000 ⁇ m and has a porosity that is about 60 to about 99.9% by volume.
- the fibers have a fineness that is about 50 nm to about 20 ⁇ m and the randomly-oriented 3-D fibrous structure further comprises interconnected pores having sizes that are about 10 to 1000 ⁇ m and has a porosity that is about 90 to about 99.9% by volume of the structure.
- the one or more fibers consist of the polymer-surfactant complex.
- the randomly-oriented 3-D fibrous structure consists of the one or more fibers and the interconnected pores.
- the randomly-oriented 3-D fibrous structure consists of one or more fibers and the interconnected pores, wherein the one or more fibers consist of the polymer-surfactant complex.
- the fibers/fibrous structure After the fibers/fibrous structure are formed it may be heat treated at a temperature that is about 70 to 150° C. to modify the water stability and mechanical properties of the fibers (e.g., tensile properties, compressive properties, abrasion properties, and bending properties).
- a temperature that is about 70 to 150° C. to modify the water stability and mechanical properties of the fibers (e.g., tensile properties, compressive properties, abrasion properties, and bending properties).
- the 2D PEG scaffold was prepared by electrospinning 10 wt % PEG (50 kDa, Sigma-Aldrich, St. Louis, Mo.) aqueous solution.
- the 3D PEG scaffold was prepared by electrospinning 10 wt % PEG and 10 wt % SDS in aqueous solution. All the electrospinning parameters, including the extrusion speed of 2 mL/hr, voltage of 42 kV, and distance from the needle to the collecting board of 25 cm, were kept the same for all the samples. The needle was negatively charged, and the collecting board was positively charged.
- the 2D and 3D scaffolds were observed using a scanning electron microscope (S3000N, Hitachi Inc. Schaumburg, Ill.) and a Nikon A1 confocal laser scanning microscope (Nikon Inc., Melville, N.Y.).
- V sp is the specific pore volume
- V pore is the volume of pores encompassed in the scaffolds
- m scaffold is the mass of scaffolds
- V scaffold is the volume of the scaffolds after precise measurement of the length, width, and thickness of scaffolds
- ⁇ material is the density of the material.
- a CCD camera with a longworking-distance lens was used in capturing the moment photographs of fiber deposition and scaffold formation.
- the time interval for each consequential photograph was 0.125 seconds.
- NIH 3T3 mouse fibroblast cells (ATCC CRL-1658, Manassas, Va.) were cultured to quantitatively estimate effects of 2D and 3D structures of zein scaffolds on cell attachment and proliferation.
- Cells were cultured in culture medium at 37° C. in a humidified 5% CO2 atmosphere.
- Electrospun 2D and 3D zein scaffolds were first rinsed in 60 wt % acetone (BDH, West Chester, Pa.) aqueous solution containing 5 wt % potassium chloride (Fisher Scientific, Fair Lawn, N.J.) to remove SDS, washed in distilled water three times, and then lyophilized.
- MTS assays were performed to quantitatively investigate cell viability at attachment and proliferation stages.
- the samples were washed with PBS, placed in new 48-well plates containing 450 ⁇ L well ⁇ 1 20% MTS reagent (CellTiter 96 Aqueous One Solution Cell Proliferation Assay, Promenade) in Dulbecco's modified Eagle's medium (DMEM) and incubated at 37° C. in a humidified 5% CO 2 atmosphere for 3 hours. After incubation, 150 ⁇ L of the solution from each well was pipetted into a 96-well plate and the optical densities were measured at 490 nm using a UV/vis multiplate spectrophotometer (Multiskan Spectrum, Thermo Scientific). The MTS solution in DMEM without cells served as the blank.
- MTS reagent CellTiter 96 Aqueous One Solution Cell Proliferation Assay, Promenade
- DMEM Dulbecco's modified Eagle's medium
- Phalloidin 633 solution (1:200 Alexa Fluor 633 Phalloidin, Invitrogen, Grand Island, N.Y.) and observed using a Nikon A1 confocal laser scanning microscope (Nikon Inc., Melville, N.Y.).
- Alexa Fluor 633 Phalloidin is a far red fluorescent dye that specifically bonds to F-actin in cells. This dye was selected since zein shows fluorescence across the full spectrum with the weakest signal in the far red range.
- a piece of 3D zein scaffold was prepared by electrospinning aqueous solution containing 25 wt % of zein and 25 wt % of sodium dodecyl sulfate (SDS), and a piece of 2D zein scaffold was prepared by electrospinning 25 wt % zein in 70% v/v aqueous ethanol solution; 9 wt % of citric acid based on the weight of zein was added into both 2D and 3D spinning dopes for crosslinking.
- Different solvent systems were utilized because the zein, itself, could not be dissolved in water.
- the electrospinning process was conducted at an extrusion speed of 2 mL/hr, a voltage of 42 kV, and a distance from the needle to the collecting board of 25 cm. The needle was negatively charged and the collecting board was positively charged.
- FIG. 3 the 3D electrospun zein scaffold has significantly higher porosity and fluffiness than its 2D counterpart with the same weight.
- FIG. 4 contains the microscopic morphologies of 3D electrospun zein scaffolds observed under scanning electron microscope (SEM, left) and confocal laser scanning microscope (CLSM, right), which show that the orientation of fibers in the 3D electrospun zein scaffold was random (from both the top surface and the side).
- SEM scanning electron microscope
- CLSM confocal laser scanning microscope
- NIH 3T3 fibroblast cells were cultured on both 2D and 3D electrospun zein scaffolds to evaluate the effects of scaffold architecture on cellular attachment, penetration and proliferation.
- Cell penetration was evaluated 48 hours after culturing the 2D and 3D scaffolds.
- Significantly higher cell accessibility of 3D zein electrospun scaffold compared with 2D scaffold is shown in FIG. 5 .
- Cells cultured on the 3D electrospun zein scaffold were found at the depth of 120 ⁇ m from the surface, whereas cells could not be seen 40 ⁇ m below the surface of the 2D electrospun zein scaffold. It is believed that the “looser” structure of the 3D electrospun scaffold accounted for the much better cellular penetration in the 3D scaffold.
- Methanethiosulfonate (MTS) assays were conducted to quantitatively investigate cell attachment and proliferation, the results of which are shown in FIG. 6 .
- the amount of cells attached on the 3D zein scaffold 4 hours after seeding was 114% higher than that on the 2D scaffold.
- a remarkably higher proliferation rate was also found for cells cultivated on 3D zein scaffold.
- Cell proliferation on the 3D scaffold reached plateau 5 days after seeding and the cell density increased more than 4 times, while that on 2D scaffold reached plateau 3 days after seeding and the increase in cell density was less than twice. It is believed that the greater cyto-accessible space of the 3D scaffold may be the reason for higher cell accessibility and better proliferation.
- FIG. 7 b shows spheroid-shaped cells on 3D scaffolds whereas FIG. 7 a shows cells with flattened morphologies on 2D scaffolds.
- FIG. 7 a .I shows he developed cytoskeletons of cells over the surface of 2D scaffold (the x-y projection).
- the thickness of the cells illustrated in the x-z projection ( FIG. 7 a .II) and the y-z projection ( FIG. 7 a .III) was much smaller than their planar sizes in the x-y projection ( FIG. 7 a .I).
- cells seeded on the 2D scaffolds developed into 2D planar morphologies.
- FIG. 7 b .II′ and III′ show that the cells oriented in thickness direction rather than in planar x and y directions. It is believed that the 3D scaffolds facilitated the cells to develop into stereoscopic architectures that more closely mimic the cells in many native ECMs.
- PEG is a water soluble synthetic polymer, and could also be electrospun into 3D stereoscopic architecture.
- PEG 25 wt %) and SDS (25 wt %) were dissolved in water to prepare spinning dopes.
- the electrospinning process was conducted at an extrusion speed of 2 mL/hr, a voltage of 42 kV, and a distance from the needle to the collecting board of 25 cm. The needle was negatively charged and the collecting board was positively charged.
- the 3D electrospun zein scaffold has significantly higher porosity and fluffiness than its 2D counterpart with the same weight.
- the 3D PEG electrospun scaffold was composed of spatially randomly oriented fibers with diameter around 0.8 ⁇ m.
- the electrospinning process was conducted at an extrusion speed of 2 mL/hr, a voltage of 42 kV, and a distance from the needle to the collecting board of 25 cm. The needle was negatively charged and the collecting board was positively charged. As is shown in FIG. 9 , the 3D electrospun zein scaffold has significantly higher porosity and fluffiness than its 2D counterpart with the same weight.
- the 3D PEG electrospun scaffold was composed of spatially randomly oriented fibers with diameter around 0.8 ⁇ m.
- Soy protein and wheat glutenin represent two types of highly crosslinked proteins that are high in molecular weights and insoluble in water. These proteins were treated in 8 M urea under mild alkaline condition with existence of cysteine, a common amino acid, which is also a nontoxic and environmentally benign reductant. After being treated at 70° C. for 24 hours, the soluble proteins were collected. SDS PAGE results of these extracted proteins showing molecular weights are shown in FIG. 10 . Lane 1 showed standard protein markers. Lanes 2, 3, and 4 were untreated soy protein, cysteine extracted soy protein and soy protein treated with NaOH.
- Soy protein extracted using protocol as mentioned in Example 4 (25 wt %) and 25 wt % of SDS were dissolved in water and electrospun into 3D structures as shown in FIG. 11 .
- the electrospinning process was conducted at an extrusion speed of 2 mL/hr, a voltage of 42 kV, and a distance from the needle to the collecting board of 25 cm.
- the needle was negatively charged and the collecting board was positively charged.
- the diameter of the ultrafine fibers ranged from 1 to 3 ⁇ m.
- the 3D electrospun soy protein scaffold was soaked in PBS at 50° C. for 3 days. As shown in FIG. 12 , the scaffold retained fibers in their structures as the diameters of fibers increased from 1-3 ⁇ m to 2-5 ⁇ m after 3 days. The 3D electrospun soy protein scaffold showed fairly good water stability.
- Feather keratin extracted using protocol as mentioned in Example 4 25 wt %), 25 wt % of SDS and cysteine (10 wt % based on keratin) were dissolved in water and electrospun into 3D structures as shown in FIG. 13 .
- the electrospinning process was conducted at an extrusion speed of 2 mL/hr, a voltage of 42 kV, and a distance from the needle to the collecting board of 25 cm.
- the needle was negatively charged and the collecting board was positively charged.
- the diameter of the ultrafine fibers ranged from 2 to 5 ⁇ m.
- Wheat glutenin extracted using protocol as mentioned in Example 4 25 wt %), 25 wt % of SDS and cysteine (10 wt % based on wheat glutenin) were dissolved in water and electrospun into 3D structures as shown in FIG. 14 .
- the electrospinning process was conducted at an extrusion speed of 2 mL/hr, a voltage of 42 kV, and a distance from the needle to the collecting board of 25 cm.
- the needle was negatively charged and the collecting board was positively charged.
- Wheat gliadin (25 wt %), a prolamin in wheat, and 25 wt % of SDS were dissolved in water and electrospun into 3D structures as shown in FIG. 15 .
- the electrospinning process was conducted at an extrusion speed of 2 mL/hr, a voltage of 42 kV, and a distance from the needle to the collecting board of 25 cm. The needle was negatively charged and the collecting board was positively charged.
- the diameter of fibers in 3D gliadin electrospun scaffold ranged from 1.5 to 3.5 ⁇ m.
- Casein 25 wt %), the family of proteins commonly found in mammalian milk, and 25 wt % of SDS were dissolved in water and electrospun into 3D structures as shown in FIG. 16 .
- the electrospinning process was conducted at an extrusion speed of 2 mL/hr, a voltage of 42 kV, and a distance from the needle to the collecting board of 25 cm.
- the needle was negatively charged and the collecting board was positively charged.
- the diameter of fibers in 3D casein electrospun scaffold ranged from 0.8 to 2.8 ⁇ m.
- Peanut protein (25 wt %) and 25 wt % of SDS were dissolved in water and electrospun into 3D structures as shown in FIG. 17 .
- the electrospinning process was conducted at an extrusion speed of 2 mL/hr, a voltage of 42 kV, and a distance from the needle to the collecting board of 25 cm.
- the needle was negatively charged and the collecting board was positively charged.
- the diameter of fibers in 3D peanut protein electrospun scaffold ranged from 0.9 to 2.9 ⁇ m.
- a power function was used to simulate the relationship between the specific pore volume of electrospun scaffolds and corresponding polymer surface resistivity. As shown in FIG. 18 a , the residual standard error of the model is 0.613, which is a reasonable number to indicate that the data could be well described by power function and suggests that there is a strong quantitative relationship between the specific pore volume and surface resistivity.
- y represented specific pore volume
- x represented surface resistivity
- a and b were coefficients varied with the type of materials.
Landscapes
- Engineering & Computer Science (AREA)
- Textile Engineering (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Mechanical Engineering (AREA)
- Manufacturing & Machinery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Spinning Methods And Devices For Manufacturing Artificial Fibers (AREA)
- Artificial Filaments (AREA)
Abstract
A randomly-oriented 3-D fibrous structure and a method for making the same. The method involves electrospinning a spinning dope with an electrospinning apparatus, wherein the spinning dope comprises: a solvent; a polymer dissolved in the solvent, wherein the dissolved polymer is in subunits having molecular weights that are about 5 to about 150 kDa; and a surfactant; to form one or more fibers that comprise a polymer-surfactant complex and that arrange randomly and evenly in three dimensions when contacting a collecting board of the electrospinning apparatus thereby forming the randomly-oriented 3-D fibrous structure.
Description
- The present application is a non-provisional application claiming the benefit of U.S. Provisional Patent Application 61/668,269, filed Jul. 5, 2012, which is incorporated herein by reference in its entirety.
- This invention was made with Government Support under a grant from the U.S. Dept. of Agriculture (NEB 37-037). The government has certain rights to this invention.
- This invention is directed to electrospinning three-dimensionally (3D) and randomly oriented fibrous structures from various polymer sources, including plant proteins, animal proteins, and synthetic polymers.
- Ideal tissue engineering scaffolds should be capable of closely mimicking the topographies and spatial structures of native extracellular matrices (ECMs) to facilitate cells to grow and differentiate following the patterns similar to that found in native tissues and organs. Morphologies of ECMs vary according to functions of target tissues and cell types in the tissues. For example, in skin tissue, the top layer is formed by compact packing of epithelial cells on a two-dimensional (2D) fibrous ECM basement membrane. Three-dimensional spatial spreading of fibroblasts and immune cells occurs in the interior region of the skin tissue, and correspondingly the ECMs are constructed by stereoscopically and randomly oriented ultrafine protein fibers. Fibrous structures with 3D orientation and random distribution can also be found in native ECMs in breast, liver, bladder, lung, and many other organs and tissues. It has been reported that cells cultured on flat 2D substrates may differ considerably in morphology and differentiation pattern from those cultured in more physiological 3D environments. Therefore, it is reasonable to fabricate scaffolds with particular morphologies and structures according to categories and functions of original native tissues.
- Due to its simplicity and high efficiency, electrospinning has been widely employed to fabricate tissue engineering scaffolds composed of nano- or submicrometer-fibers from numerous materials. However, conventional electrospun structures typically form 2D scaffolds with fibers aligned parallel to the collector and cells cultured on the conventional electrospun scaffolds could only develop into flat shapes. The functions and differentiation of many flattened cells could not resemble the native stereoscopic cells. Furthermore, small pore sizes, owing to the close arrangement of fibers, restricted access of cells to the interior of conventional electrospun scaffolds. Thus, on conventional electrospun scaffolds, cells could mainly spread and distribute within a shallow depth beneath the surface.
- To date, many 3D electrospinning techniques have been developed to fabricate electrospun scaffolds with larger pores and higher porosity to improve cell accessibility of the scaffolds. Examples of such techniques include wet electrospinning, electrospinning with integration of coarse fibers, and electrospinning with porogens (e.g., dry ice, salt, or sucrose), which are based on the concept of including a “blocking agent” to increase the distances between electrospun fibers in order to lead to deeper penetration of cells into interior of scaffolds. Nonetheless, these techniques failed to change the planar orientations of the electrospun fibers and as a result the scaffolds tended to have parallel fibrous layer-by-layer structures. Additionally, the parallel fibrous layer-by-layer structures tended to not have pores that extend very far in the thickness direction as compared to in the planar directions. As a result, there was limited improvement in scaffold porosity and cells cultured thereon tended to have flattened morphologies rather than stereoscopically developed cells in many native tissues. Still further, there have been attempts to fabricate 3D electrospun scaffolds based on the electrostatic repulsion between as-spun fibers. Despite their fluffy appearances, such scaffolds still had a layer-by-layer structure of planar mats and parallel oriented fibers.
- In view of the foregoing, a need still exists for randomly-oriented 3-D fibrous structures and a method for making the same via electrospinning.
- In one embodiment, the present invention is directed to a method of making a randomly-oriented 3-D fibrous structure. The method comprising electrospinning a spinning dope with an electrospinning apparatus, wherein the spinning dope comprises: a solvent; a polymer dissolved in the solvent, wherein the dissolved polymer is in subunits having molecular weights that are about 5 to about 150 kDa; and a surfactant; to form one or more fibers that comprise a polymer-surfactant complex and that arrange randomly and evenly in three dimensions when contacting a collecting board of the electrospinning apparatus thereby forming the randomly-oriented 3-D fibrous structure.
- In one embodiment, the present invention is directed to a method of making a randomly-oriented 3-D fibrous structure. The method comprising electrospinning a spinning dope with an electrospinning apparatus, wherein the spinning dope comprises: a solvent; a polymer dissolved in the solvent, wherein the dissolved polymer is in subunits having molecular weights that are about 5 to about 150 kDa, and wherein the polymer is selected from the group consisting of protein, synthetic polymer, and combinations thereof; and an anionic surfactant at about 5 to about 300 percent by weight of the polymer; to form one or more fibers of a fineness that is about 50 nm to about 100 μm and that comprise a polymer-surfactant complex and that arrange randomly and evenly in three dimensions when contacting a collecting board of the electrospinning apparatus thereby forming the randomly-oriented 3-D fibrous structure that further comprises interconnected pores having sizes that are about 10 to 2000 μm and that has a porosity that is about 60 to about 99.9% by volume.
- In one embodiment, the present invention is directed to a randomly-oriented 3-D fibrous structure comprising: one or more fibers that comprise a polymer-surfactant complex, wherein the fiber(s) have lengths that are at least about 100 nm and finenesses that are about 50 nm to about 100 μm, and are arranged randomly and evenly in three dimensions throughout the randomly-oriented 3-D fibrous structure; and interconnected pores having sizes that are about 10 to 2,000 μm, wherein the pores comprise about 60 to about 99.9% by volume of the randomly-oriented 3-D fibrous structure.
-
FIG. 1 contains schematic diagrams of fibers being deposited via electrospinning in which the 2D column contains images (a), (b), and (c) showing the parallel deposition of conventional electrospun fibers and the 3D column contains images (d), (e), and (f) showing the deposition of fibers according to the present invention. -
FIG. 2 contains photographic images of fibers being deposited via electrospinning in which the (a) column contains 1, 2, and 3, which were taken at 0.125 second intervals showing the deposition of conventional, parallel-aligned electrospun fibers and the (b) column containsimages 1, 2, and 3, which were taken at 0.125 second intervals showing the vertical deposition of fibers according to the present invention.images -
FIG. 3 is a photographic comparison of a zein electrospun randomly-oriented 3-D fibrous structure and azein electrospun 2D fibrous structure; the structures are of the same weight. -
FIG. 4 are images of a zein electrospun randomly-oriented 3-D fibrous structure: (a) is a SEM 70x top view image; (b) is a SEM 70x side view image; (c) is a CLSM 100x 45 degree front view image; and (d) is a CLSM 100x side view image. -
FIG. 5 are CLSM 60x images of sequential sections of 2D [(a) 1, 2, 3, and 4] and randomly-oriented 3-D fibrous structures [(b) 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12] each taken at increasing 10 μm depths in which the lighter network is F-actin in NIH 3T3 cells stained with Phalloidin 633 after being cultured in the structures for 72 hours. -
FIG. 6 is graph of MTS assay results of attachment (4 hours) and proliferation (24, 72, 120, and 168 hours) of NIH 3T3 fibroblase cells on 2D and 3D zein electrospun fibrous structures. -
FIG. 7 are CLSM images showing the proliferation of NIH 3T3 cells on 2D and 3D zein electrospun fibrous structures about 48 hours after seeding (stained with Phalloidin 633 and Hoechst 33342). The three-dimensional reconstruction of the 2D fibrous structure is (a): x-y projection (I); x-z projection (II′); and y-z projection (III). The three-dimensional reconstruction of the 3D fibrous structures is (b): x-y projection (I′); x-z projection (II′); and y-z projection (III′). -
FIG. 8 is a photographic comparison of an electrospun randomly-oriented 3-D PEG fibrous structure prepared with SDS and anelectrospun 2D fibrous structure; the structures are of the same weight. -
FIG. 9 is a photograph of a PEG electrospun randomly-oriented 3-D fibrous structure prepared with a nonionic surfactant. -
FIG. 10 is a SDS-PAGE of soy protein, and wheat glutenin, whereinlane 1 shows standard protein markers,lane 2 is untreated soy protein,lane 3 is cysteine extracted soy protein,lane 4 is NaOH extracted soy protein,lane 5 is untreated wheat glutenin, andlane 6 is cysteine extracted wheat glutenin. -
FIG. 11 is a photograph of a soy protein electrospun randomly-oriented 3-D fibrous structure. -
FIG. 12 is are photographs of soy protein electrospun randomly-oriented 3-D fibrous structure, wherein (a) is before immersion in PBS and (b) is 3 days after immersion in PBS; scale bar is 20 μm. -
FIG. 13 is a photograph of a feather keratin electrospun randomly-oriented 3-D fibrous structure. -
FIG. 14 is a photograph of a wheat glutenin electrospun randomly-oriented 3-D fibrous structure. -
FIG. 15 is a photograph of a wheat gliadin electrospun randomly-oriented 3-D fibrous structure. -
FIG. 16 is a photograph of a casein electrospun randomly-oriented 3-D fibrous structure. -
FIG. 17 is photograph of a peanut electrospun randomly-oriented 3-D fibrous structure. -
FIG. 18 (a) is graph showing the relationship between specific pore volume of electrospun scaffolds and surface resistivity (the dashed line shows the simulated relation using power function) andFIG. 18 (b) is a graph showing the effect of sodium dodecyl sulfate (SDS) and NaCl on surface resistivity of PEG films based on the proportions of SDS to polymer (the molar concentration of NaCl was the same as that of SDS at each point). -
FIG. 19 (a) are photographs of the deposition process of zein onto an insulator covered collector at time intervals of 0.125 seconds between each image (the spinning dope consisted of 25 wt % zein and 25 wt % SDS);FIG. 19 (b) is a photograph of the as-spun zein scaffold; andFIG. 19( c) is a CLSM 45° image at magnification of 100× of the above as-spun zein scaffold. - An embodiment of the present invention is directed to a method of making a randomly-oriented 3-D fibrous structure. The method comprising electrospinning a spinning dope with an electrospinning apparatus, wherein the spinning dope comprises: a solvent; a polymer dissolved in the solvent, wherein the dissolved polymer is in subunits having molecular weights that are about 5 to about 150 kDa; and a surfactant; to form one or more fibers that comprise a polymer-surfactant complex and that arrange randomly and evenly in three dimensions when contacting a collecting board of the electrospinning apparatus thereby forming the randomly-oriented 3-D fibrous structure. Typically, the electrospinning is conducted at a temperature that is about 25 to about 70° C.
- As used herein with respect to the present invention, the “randomly-oriented 3-D fibrous structure” is intended to mean fibrous structure in which the one or more fibers thereof are randomly oriented in all three dimensions rather than only being randomly oriented in two dimensions as can be found in conventional layer-by-layer, planar structures. The degree of random orientation of a fibrous structure may be quantified by, for example, identifying a cubic centimeter volume of said fibrous structure and identifying any particular imaginary plane of any orientation within said volume, identifying the number of fibers intersected or fiber intersections both of which are “intersections” with said plane, and identifying the number of said intersections in which said intersected fiber(s) are at angles greater than 30 degrees relative to said plane. In certain embodiments of the present invention, at least ½, ⅝, ⅔, and ¾ of the intersected fibers are at angles greater than 30 degrees with the plane.
- As used herein the terms “scaffold” and “fibrous structure” are intended to have the same meaning and may be used interchangeably.
- Without being bound to any particular theory, it is believed that the mechanisms of 2D electrospinning and an embodiment of 3D electrospinning (of the present invention produce) are depicted in
FIG. 1 . In both conventional and 3D electrospinning, at the beginning, the liquid droplet acquired negative charges and then was elongated into fibers. For conventional electrospinning, relatively few of the electrons are transferred to the collector at the moment the fiber ends hit the collector, owing to high surface resistivity of the fibers. The fibers with a relatively large amount of remaining electrons are strongly attracted to the positively charged collector. As a consequence, conventional 2D electrospun scaffolds have fibers oriented parallel to the collecting board and the fibrous structures are relatively tightly packed. - In contrast, the depicted 3D electrospinning embodiment is believed to be based on repulsive electrical force between fibers and the collector. More specifically, the method of the present invention, involves including a surfactant to decrease the surface resistivity of a fiber to thereby increase the transfer of charge from the fiber surface to the collector. When the fiber(s) strike the collector, surface static electricity transfers to the board in a faster manner, which results in less negative static electricity remaining on the fiber(s), and decreased attraction between fiber(s) and the collector. In some cases, the near portion of the fibers may even carry positive charges and may be repulsed by the collector, while the farther end of the fiber(s) is still attracted and moves towards the board. As a result, fiber(s) are collected onto the board in multiple orientations to form loose and fluffy 3D scaffolds with randomly-oriented fiber(s).
- It is believed that the above-described mechanisms have been shown by experimental results shown in
FIG. 2 in whichFIG. 2 a is conventional electrospinning andFIG. 2 b is electrospinning in accordance with the present invention at 0.125 second intervals between sequential photographs with the the white objects PEG fibrous bulks. - As indicated above, the spinning dope comprises a polymer, which may be any appropriate polymer such as protein, synthetic polymer, and combinations thereof. Proteins may be of particular interest because they are preferred in biomedical applications due to their molecular similarity to native ECMs, and tend to be widely available at low cost. For example, plant proteins, zein and soy protein, and animal proteins, such as keratin and collagen, have been proved to be supportive to cell growth in in vitro and in vivo studies. In addition, plant and animal proteins are widely available at a low cost and they are considered to be a renewable resource. The method of the present invention may be conducted using one or more proteins selected from the group consisting of plant protein, animal protein, and combinations thereof.
- Many such proteins, however, are considered to be highly-linked and as a result tend to have limited solubility in water and organic or alcoholic solvents. In general, proteins with cysteine content higher than 1% in its amino acid composition are considered to be highly-crosslinked proteins. Exemplary highly-crosslinked proteins, including keratin, which has a cysteine content of about 7%, soy protein has a cysteine content of about 1.3%, and wheat glutenin a cysteine content of about 2%. In particular, electrospinning highly crosslinked proteins, such as soy protein, feather keratin and wheat glutenin, into fibrous structures via electrospinning has not been possible due to their insolubility in various solvents.
- With reductant and denaturant in the spinning dope, coarse fibers from soy protein and wheat gluten via wet spinning have been produced. Reddy, N. and Y. Yang, Novel Protein Fibers from Wheat Gluten, Biomacromolecules, 2007, 8(2), p. 638-643; Reddy, N. and Y. Yang, Soy protein fibers with high strength and water stability for potential medical applications, Biotechnology Progress, 2009, 25(6), p. 1796-1802. However, electrospinning with pure protein required much better dissolution of proteins, and thus the spinning dope for wet spinning failed to be electrospun. Highly hydrolyzed soy protein with small molecules had been electrospun with PEG, which accounted for the spinability. Vega-Lugo, A. C. and L. Loong-Tak, Electrospinning of Soy Protein Isolate Nanofibers, Journal of Biobased Materials and Bioenergy, 2008, 2(3), p. 223-230. Hydrolyzed soy protein in its pure form, however, had not been electrospun.
- The present invention of electrospinning may be practiced, however, with highly crosslinked protein by dissolving the protein in manner that preserves the protein subunits with appropriate molecular weights ranging from 5 to 150 kDa. Other methods of dissolving highly crosslinked proteins (e.g., U.S. Pat. Pub. No. 2006/0282958, Yang et al., entitled Process for the Production of High Quality Fibers from Wheat Proteins and Products Made From Wheat Proteins) allowed for the spinning of coarse fibers but were not suitable for electrospinning of relatively fine fibers. The electrospinning method of the present invention may be practiced with highly crosslinked proteins by using a reducing agent such a thiol, a sulfite, or a sulfide to break the disulfide bonds of the highly crosslinked proteins. For example, cysteine, an environmentally-benign thiol, may be used as a reducing agent to break the disulfide bonds and achieve dissolution of highly-crosslinked proteins. The amount of the reducing agent in the solution may be varied from about 1% to about 50% based on the weight of proteins. The solvent for the protein and cysteine was a 4-8 M urea solution with pH of 8 to 12, adjusted using 50 wt % sodium hydroxide solution. The weight ratio of protein-containing materials to urea solution may be varied within a range from, for example, 1:5 to 1:30. The temperature for the dissolution may be within a range from about 20° C. to about 90° C. Examples of additional appropriate thiols include methanethiol, ethanethiol, 1-propanethiol, 2-propanethiol, butanethiol, tert-butyl mercaptan, pentanethiols, thiophenol, thioacetic acid, coenzyme-A, glutathione, 2-mercaptoethanol, dithiothreitol, 2-mercaptoindole, 3-mercaptopropane-1,2-diol. Examples of appropriate sulfites and sulfides include sodium sulfite potassium sulfite, sodium bisulfite, potassium bisulfite, sodium sulfide, potassium sulfide, sodium metabisulfite, and potassium metabisulfite. The conditions for the reactions include the thiol/sulfite/sulfide at concentration(s) of about 0.5% to about 50% based on the weight of proteins, a pH from 3 to 12 for a duration of about 30 minutes to about 24 hours at a temperature of about 20° C. to about 90° C.
- In view of the foregoing, the method of the present invention may, in certain embodiments, be conducted using appropriately dissolved highly-crosslinked plant protein, highly-crosslinked animal protein, and combinations thereof. When using proteins, including highly-crosslinked proteins, experimental results to date have shown the aging the dissolved protein at an aging temperature that is about 20° C. to about 90° C. for an aging duration that is about 0.5 to about 48 hours before conducting the electrospinning may be advantageous. For example, it has been found that such aging may provide a higher degree of disentanglement of the protein molecules to improve the spinnability of the protein spinning dope.
- Exemplary plant proteins include wheat gluten, wheat gliadin, wheat glutenin, soy protein, camelina protein, peanut protein, canola protein, sorghum protein, rice protein, millet protein, sunflower seed protein, pumpkin seed protein, mung bean protein, red bean protein, chickpea protein, green pea protein, and combinations thereof;
- Exemplary animal proteins include chicken feather, egg white, wool keratin, casein, silk, fibrin, collagen, gelatin, hair keratin, horn keratin, nail keratin, whey protein, and combinations thereof.
- Exemplary synthetic polymers include polyethylene glycol (PEG), poly lactic acid (PLA), poly glycolic acid (PGA), polyhydroxyalkanoates (PHAs), poly(lactic-co-glycolic acid) (PLGA), poly-3-hydroxybutyrate (PHB), polyhydroxyvalerate (PHV), polyhydroxyhexanoate (PHH), poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV), and combinations thereof.
- As indicated above, the solution may comprise one, two, or even more polymers. In certain embodiments with more than a single polymer, the polymer that is in the largest amount (usually more than half of the total polymer content) is often referred to as the “primary” polymer, component, or material and the additional polymers are often referred to as “secondary” polymer(s), component(s), or material(s) with concentrations that are from about 0.5% to about 50% by weight of the primary polymer.
- As indicated above, the spinning dope comprises a surfactant, which may be any appropriate surfactant. The hydrophobic portions of surfactant bond with polymers through hydrophobic interaction to form a protein-surfactant complex. Without being bound to a particular theory, it is believed that the hydrophilic portions, including functional groups that carry positive or negative charges and polar uncharged groups, gather on the fiber surface and thus effectively increase the surface conductivity (or lower the surface resistivity) by introducing surface water layer, which facilitates delivery of charges on the surface.
- The surfactant(s) may be of different hydrocarbon chain lengths and different electrical properties, including anionic surfactants, cationic surfactants, nonionic surfactants, zwitterionic surfactants. In an embodiment, combinations of surfactants may be used, as appropriate. In another embodiment, the surfactant is one or more anionic surfactants.
- Typically, the spinning dope has a concentration of the surfactant that is about 5 to about 300 percent by weight of the polymer. In another embodiment, the spinning dope has a concentration of the surfactant that is about 50 to about 150 percent by weight of the polymer.
- Exemplary anionic surfactants include sodium dodecyl sulfate, sodium dodecyl benzenesulfonate, sodium lauryl sarcosinate, perflourobutanesulfonic acid, ammonium lauryl sulfate, sodium stearate, sodium pareth sulfate, dioctyl sodium sulfosuccinate, potassium lauryl sulfate, sodium laureth sulfate, sodium myreth sulfate, and combinations thereof.
- Exemplary cationic surfactants include benzalkonium chloride, cetrimonium bromide, tetramethylammonium hydroxide, octenidine dihydrochloride cetyl trimethylammonium bromide, hexadecyl trimethyl ammonium bromide, cetyl trimethylammonium chloride (CTAC), cetylpyridinium chloride (CPC), benzalkonium chloride (BAC), benzethonium chloride (BZT), 5-bromo-5-nitro-1,3-dioxane, dimethyldioctadecylammonium chloride, cetrimonium bromide, dioctadecyldimethylammonium bromide (DODAB), and combinations thereof.
- Exemplary nonionic surfactants include decyl glucoside, octyl phenol ethoxylated, polysorbate 80,
polysorbate 20, and combinations thereof. - Exemplary zwitterionic surfactants include cocamidopropyl hydroxysultaine, cocamidopropyl betaine, lecithin, 3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS), 3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonate (CHAPSO), and combinations thereof.
- As indicated above, the spinning dope comprises a solvent, which may be any appropriate solvent. Exemplary solvents include water, phosphate buffered saline (PBS), carbonate buffer, tris-glycine buffer, borate buffer, acetate buffer, n-cyclohexyl-2-aminoethanesulfonic acid (CHES) buffer, citric buffer, ethanol, chloroform, 1,4-dioxane, methanol, ethylene glycol, acetone, ethyl acetate, methyl acetate, hexane, petrol ether, citrus terpenes, diethyl ether, dichloromethane, dimethylformamide (DMF), acetonitrile (MeCN), dimethyl sulfoxide (DMSO), formic acid, n-butanol, isopropanol (IPA), n-propanol, acetic acid, nitromethane, dichloromethane, and combinations thereof. In another embodiment, the solvent is selected from the group consisting of water, phosphate buffered saline (PBS), carbonate buffer, tris-glycine buffer, borate buffer, acetate buffer, n-cyclohexyl-2-aminoethanesulfonic acid (CHES) buffer, citric buffer, chloroform, and combinations thereof.
- In addition to the above-described components, the spinning dope may comprise one or more additional components such as a cross-linker, a sacrificial component, or a combination thereof. Alternatively or in addition to including such additional components in the spinning dope, the method may further comprise contacting the fibers with a second solution that comprises a second cross-linker, a surface decorator, or a combination thereof.
- Cross-linker(s)
- Exemplary cross-linkers include polycarboxylic acid which contains at least three carboxylic acid groups (such as citric acid, iso-citric acid, propane-1,2,3-tricarboxylic acid, trimesic acid, aconitic acid, mellitic acid, 1,2,3,4-Butane tetracarboxylic acid (BTCA)), oxysucrose, genepin, glutaraldehyde, oxaldehyde, NHS esters, maleimides, carbodiimide, isocyanate, and combinations thereof. If present in the spinning dope and/or in a cross-linking solution, the concentration of cross-linker is typically about 0.01 mol/L to about 10 mol/L. In an embodiment in which the spinning dope comprises a first cross-linker and the method further comprises contacting the fibers with a cross-linking solution that comprises a second cross-linker, the first and second cross-linkers may be independently selected and as such may be identical or different (e.g., in terms of material, concentration, or both). In an embodiment of the present invention, the first and second cross-linkers are independently selected from the group consisting citric acid, 1,2,3,4-Butane tetracarboxylic acid (BTCA), oxysucrose, genepin, glutaraldehyde, oxaldehyde, and combinations thereof.
- Sacrificial Component
- Exemplary sacrificial components include PEG, egg white protein, zein, wheat gliadin, and other materials that may be dissolved with the above-described polymer(s) before electrospinning at concentrations of about 0.5% to about 50% based on the weight of the polymer. The sacrificial component(s) may be removed from the spun fibrous structure via rinsing with water, organic solvents or alcoholic solvents.
- Surface Decorator
- Exemplary surface decorators of fibers include peptides such as Arg-Gly-Asp (RGD), Ile-Lys-Val-Ala-Val (IKVAV), Asn-Ser-Gly-Ala-Ile-Thr-Ile-Gly (NSGAITIG), and combinations thereof at concentrations of about 0.5% to about 10% based on the weight of the polymer.
- The method may further comprise contacting the fibers with a coagulation solution that comprises a coagulant to modify the water stability and mechanical properties of the fibers (e.g., tensile properties, compressive properties, abrasion properties, and bending properties). Exemplary coagulants include methanol, ethanol, sodium sulfate and acetic acid, acetone, sulfuric acid, hydrochloric acid, and combinations thereof. In an embodiment of the present invention, the coagulant is selected from the group consisting of methanol, ethanol, sodium sulfate and acetic acid, and combinations thereof. The amount of coagulant in the coagulant solution is such that the concentration of coagulant is typically about 1% to about 100%. Typically, the fibers are contacted with the coagulation solution for a duration of about 5 minutes to about 24 hours. Also, the coagulation solution is typically at a temperature that is from about 20° C. to about 100° C.
- The above described method may be performed to make a randomly-oriented 3-D fibrous structure. Such a fibrous structure comprises: one or more fibers that comprise a polymer-surfactant complex, wherein the fiber(s) have lengths that are at least about 100 nm and finenesses that are about 50 nm to about 100 μm, and are arranged randomly and evenly in three dimensions throughout the randomly-oriented 3-D fibrous structure; and interconnected pores having sizes that are about 10 to 2,000 μm, wherein the pores comprise about 60 to about 99.9% by volume of the randomly-oriented 3-D fibrous structure. Advantageously, experimental results to date indicated that such randomly-oriented, three-dimensionally fibrous structures may be used to facilitate cells to grow and spread in three dimensions in a manner similar to that seen in native ECMs.
- In another embodiment, the fibers have a fineness that is about 50 nm to about 100 μm and the randomly-oriented 3-D fibrous structure further comprises interconnected pores having sizes that are about 10 to 2000 μm and has a porosity that is about 60 to about 99.9% by volume.
- In yet another embodiment, the fibers have a fineness that is about 50 nm to about 20 μm and the randomly-oriented 3-D fibrous structure further comprises interconnected pores having sizes that are about 10 to 1000 μm and has a porosity that is about 90 to about 99.9% by volume of the structure.
- In an embodiment, the one or more fibers consist of the polymer-surfactant complex. In another embodiment, the randomly-oriented 3-D fibrous structure consists of the one or more fibers and the interconnected pores. In yet another embodiment, the randomly-oriented 3-D fibrous structure consists of one or more fibers and the interconnected pores, wherein the one or more fibers consist of the polymer-surfactant complex.
- After the fibers/fibrous structure are formed it may be heat treated at a temperature that is about 70 to 150° C. to modify the water stability and mechanical properties of the fibers (e.g., tensile properties, compressive properties, abrasion properties, and bending properties).
- Scaffold Preparation
- Thirty 2D zein scaffolds were prepared by electrospinning 25 wt % zein (Freeman Industries LLC, Tuckahoe, N.Y.) in 70% v/v aqueous ethanol (EMD Chemicals Inc., Gibbstown, N.J.) solution. Three dimensional zein scaffolds were prepared by electrospinning aqueous solution containing 25 wt % zein and 25 wt % SDS. A concentration of 9 wt % (based on the weight of zein) citric acid (EMD Chemicals Inc., Gibbstown, N.J.) was added into both 2D and 3D spinning dopes for cross-linking. Different solvent systems were utilized since zein could not be dissolved in water. The 2D PEG scaffold was prepared by electrospinning 10 wt % PEG (50 kDa, Sigma-Aldrich, St. Louis, Mo.) aqueous solution. The 3D PEG scaffold was prepared by electrospinning 10 wt % PEG and 10 wt % SDS in aqueous solution. All the electrospinning parameters, including the extrusion speed of 2 mL/hr, voltage of 42 kV, and distance from the needle to the collecting board of 25 cm, were kept the same for all the samples. The needle was negatively charged, and the collecting board was positively charged.
- Morphologies and Structures of Scaffolds
- The 2D and 3D scaffolds were observed using a scanning electron microscope (S3000N, Hitachi Inc. Schaumburg, Ill.) and a Nikon A1 confocal laser scanning microscope (Nikon Inc., Melville, N.Y.).
- Specific Pore Volume
- Specific pore volume indicating volume of pore in unit mass of scaffolds as shown in the following equation was selected to evaluate fluffiness of the scaffolds:
-
- where Vsp is the specific pore volume, Vpore is the volume of pores encompassed in the scaffolds, mscaffold is the mass of scaffolds, Vscaffold is the volume of the scaffolds after precise measurement of the length, width, and thickness of scaffolds, and ρmaterial is the density of the material.
- Surface Resistivity
- Since the surface resistivity of ultrafine fibers is very difficult to test, films containing same polymer to surfactant/salt ratio with relevant electrospun fibers were prepared to measure the surface resistivity. The films were casted onto Teflon coated plates and dried at 20° C. and 65% relative humidity. Surface resistivity was measured by employing a surface resistivity tester (Monroe Electronics Inc., Lyndonville, N.Y.) according to ASTM D-257 standard.
- Fiber Deposition Process
- A CCD camera with a longworking-distance lens was used in capturing the moment photographs of fiber deposition and scaffold formation. The time interval for each consequential photograph was 0.125 seconds.
- Cell Attachment and Proliferation
- NIH 3T3 mouse fibroblast cells (ATCC CRL-1658, Manassas, Va.) were cultured to quantitatively estimate effects of 2D and 3D structures of zein scaffolds on cell attachment and proliferation. Cells were cultured in culture medium at 37° C. in a humidified 5% CO2 atmosphere.
2D and 3D zein scaffolds were first rinsed in 60 wt % acetone (BDH, West Chester, Pa.) aqueous solution containing 5 wt % potassium chloride (Fisher Scientific, Fair Lawn, N.J.) to remove SDS, washed in distilled water three times, and then lyophilized. MTS assays were performed to quantitatively investigate cell viability at attachment and proliferation stages. Samples were prepared with same weight and then were subjected to sterilization at 120° C. for 1 hour. After sterilization, the scaffolds were placed in 48-well culture plates (TPP Techno Plastic Products, Switzerland). Fibroblast cells were seeded onto the scaffolds (1×105 cells mL−1, 500 μL well−1) and then cultured at 37° C. in a humidified 5% CO2 atmosphere for different time intervals. At each time point, the samples were washed with PBS, placed in new 48-well plates containing 450 μL well−1 20% MTS reagent (CellTiter 96 Aqueous One Solution Cell Proliferation Assay, Promenade) in Dulbecco's modified Eagle's medium (DMEM) and incubated at 37° C. in a humidified 5% CO2 atmosphere for 3 hours. After incubation, 150 μL of the solution from each well was pipetted into a 96-well plate and the optical densities were measured at 490 nm using a UV/vis multiplate spectrophotometer (Multiskan Spectrum, Thermo Scientific). The MTS solution in DMEM without cells served as the blank.Electrospun - Cell Penetration and Spreading
- To compare penetration ability of cells on 2D and 3D scaffolds, cells were stained by Phalloidin 633 solution (1:200 Alexa Fluor 633 Phalloidin, Invitrogen, Grand Island, N.Y.) and observed using a Nikon A1 confocal laser scanning microscope (Nikon Inc., Melville, N.Y.). Alexa Fluor 633 Phalloidin is a far red fluorescent dye that specifically bonds to F-actin in cells. This dye was selected since zein shows fluorescence across the full spectrum with the weakest signal in the far red range. To observe the spreading behaviors and stereoscopic morphologies of cells in 2D and 3D scaffolds, cells were stained by Phalloidin 633 solution for F-actin and Hoechst 33342 solution (Invitrogen, Grand Island, N.Y.) for the nuclei of cells.
- Statistical Analysis
- One-way analysis of variance with Tukey's pairwise multiple comparisons was employed to analyze the data. The confidence interval was set at 95%, and a P value less than 0.05 was considered to be a statistically significant difference. In the results, data labeled with different symbols were significantly different from each other.
- Ex. 1: Morphology of 3D Electrospun Zein Scaffolds
- A piece of 3D zein scaffold was prepared by electrospinning aqueous solution containing 25 wt % of zein and 25 wt % of sodium dodecyl sulfate (SDS), and a piece of 2D zein scaffold was prepared by electrospinning 25 wt % zein in 70% v/v aqueous ethanol solution; 9 wt % of citric acid based on the weight of zein was added into both 2D and 3D spinning dopes for crosslinking. Different solvent systems were utilized because the zein, itself, could not be dissolved in water. The electrospinning process was conducted at an extrusion speed of 2 mL/hr, a voltage of 42 kV, and a distance from the needle to the collecting board of 25 cm. The needle was negatively charged and the collecting board was positively charged.
- As is shown in
FIG. 3 , the 3D electrospun zein scaffold has significantly higher porosity and fluffiness than its 2D counterpart with the same weight.FIG. 4 contains the microscopic morphologies of 3D electrospun zein scaffolds observed under scanning electron microscope (SEM, left) and confocal laser scanning microscope (CLSM, right), which show that the orientation of fibers in the 3D electrospun zein scaffold was random (from both the top surface and the side). - Ex. 2: In Vitro Cell Culture Study of 3D and 2D Electrospun Zein Scaffolds
- NIH 3T3 fibroblast cells were cultured on both 2D and 3D electrospun zein scaffolds to evaluate the effects of scaffold architecture on cellular attachment, penetration and proliferation. Cell penetration was evaluated 48 hours after culturing the 2D and 3D scaffolds. Significantly higher cell accessibility of 3D zein electrospun scaffold compared with 2D scaffold is shown in
FIG. 5 . Cells cultured on the 3D electrospun zein scaffold were found at the depth of 120 μm from the surface, whereas cells could not be seen 40 μm below the surface of the 2D electrospun zein scaffold. It is believed that the “looser” structure of the 3D electrospun scaffold accounted for the much better cellular penetration in the 3D scaffold. - Methanethiosulfonate (MTS) assays were conducted to quantitatively investigate cell attachment and proliferation, the results of which are shown in
FIG. 6 . The amount of cells attached on the3D zein scaffold 4 hours after seeding was 114% higher than that on the 2D scaffold. A remarkably higher proliferation rate was also found for cells cultivated on 3D zein scaffold. Cell proliferation on the 3D scaffold reachedplateau 5 days after seeding and the cell density increased more than 4 times, while that on 2D scaffold reachedplateau 3 days after seeding and the increase in cell density was less than twice. It is believed that the greater cyto-accessible space of the 3D scaffold may be the reason for higher cell accessibility and better proliferation. - 3D zein scaffolds showed a great potential for tissue engineering applications. For example,
FIG. 7 b shows spheroid-shaped cells on 3D scaffolds whereasFIG. 7 a shows cells with flattened morphologies on 2D scaffolds. More specifically,FIG. 7 a.I shows he developed cytoskeletons of cells over the surface of 2D scaffold (the x-y projection). The thickness of the cells illustrated in the x-z projection (FIG. 7 a.II) and the y-z projection (FIG. 7 a.III) was much smaller than their planar sizes in the x-y projection (FIG. 7 a.I). As can be seen, cells seeded on the 2D scaffolds developed into 2D planar morphologies. In contrast, the side views of 3D scaffolds inFIG. 7 b.II′ and III′ show that the cells oriented in thickness direction rather than in planar x and y directions. It is believed that the 3D scaffolds facilitated the cells to develop into stereoscopic architectures that more closely mimic the cells in many native ECMs. - Ex. 3: Morphology of 3D Electrospun PEG Scaffolds Using Anionic Surfactant
- PEG is a water soluble synthetic polymer, and could also be electrospun into 3D stereoscopic architecture. PEG (25 wt %) and SDS (25 wt %) were dissolved in water to prepare spinning dopes. The electrospinning process was conducted at an extrusion speed of 2 mL/hr, a voltage of 42 kV, and a distance from the needle to the collecting board of 25 cm. The needle was negatively charged and the collecting board was positively charged. As is shown in
FIG. 8 , the 3D electrospun zein scaffold has significantly higher porosity and fluffiness than its 2D counterpart with the same weight. The 3D PEG electrospun scaffold was composed of spatially randomly oriented fibers with diameter around 0.8 μm. - Ex. 4: Morphology of 3D Electrospun PEG Scaffolds Using Nonionic Surfactant
- PEG (25 wt %) and TRITON X-100 (25 wt %), a nonionic surfactant, was dissolved in water for spinning. The electrospinning process was conducted at an extrusion speed of 2 mL/hr, a voltage of 42 kV, and a distance from the needle to the collecting board of 25 cm. The needle was negatively charged and the collecting board was positively charged. As is shown in
FIG. 9 , the 3D electrospun zein scaffold has significantly higher porosity and fluffiness than its 2D counterpart with the same weight. The 3D PEG electrospun scaffold was composed of spatially randomly oriented fibers with diameter around 0.8 μm. - Ex. 5: Extraction of Spinable Proteins from Soy Protein and Wheat Glutenin
- Soy protein and wheat glutenin represent two types of highly crosslinked proteins that are high in molecular weights and insoluble in water. These proteins were treated in 8 M urea under mild alkaline condition with existence of cysteine, a common amino acid, which is also a nontoxic and environmentally benign reductant. After being treated at 70° C. for 24 hours, the soluble proteins were collected. SDS PAGE results of these extracted proteins showing molecular weights are shown in
FIG. 10 .Lane 1 showed standard protein markers. 2, 3, and 4 were untreated soy protein, cysteine extracted soy protein and soy protein treated with NaOH. The major bands (20 kDa, 37 kDa and 63 kDa) of soy protein remained in the extracted sample, while no obvious bands could be found in the NaOH treated sample.Lanes 5 and 6 were wheat glutenin and cysteine extracted wheat glutenin. The highly similar bands of the two samples revealed the high efficient yet non-destructive manner of cysteine extraction.Lane - Ex. 6: Morphology of 3D Electrospun Scaffold from Soy Protein
- Soy protein extracted using protocol as mentioned in Example 4 (25 wt %) and 25 wt % of SDS were dissolved in water and electrospun into 3D structures as shown in
FIG. 11 . The electrospinning process was conducted at an extrusion speed of 2 mL/hr, a voltage of 42 kV, and a distance from the needle to the collecting board of 25 cm. The needle was negatively charged and the collecting board was positively charged. The diameter of the ultrafine fibers ranged from 1 to 3 μm. - Ex. 7: Water Stability of 3D Electrospun Soy Protein Scaffold
- After post treatment of coagulation bath of 10% Na2SO4 and 10% acetic acid, the 3D electrospun soy protein scaffold was soaked in PBS at 50° C. for 3 days. As shown in
FIG. 12 , the scaffold retained fibers in their structures as the diameters of fibers increased from 1-3 μm to 2-5 μm after 3 days. The 3D electrospun soy protein scaffold showed fairly good water stability. - Ex. 8 Morphology of 3D Electrospun Scaffold from Feather Keratin
- Feather keratin extracted using protocol as mentioned in Example 4 (25 wt %), 25 wt % of SDS and cysteine (10 wt % based on keratin) were dissolved in water and electrospun into 3D structures as shown in
FIG. 13 . The electrospinning process was conducted at an extrusion speed of 2 mL/hr, a voltage of 42 kV, and a distance from the needle to the collecting board of 25 cm. The needle was negatively charged and the collecting board was positively charged. The diameter of the ultrafine fibers ranged from 2 to 5 μm. - Ex. 9 Morphology of 3D Electrospun Scaffold from Wheat Glutenin
- Wheat glutenin extracted using protocol as mentioned in Example 4 (25 wt %), 25 wt % of SDS and cysteine (10 wt % based on wheat glutenin) were dissolved in water and electrospun into 3D structures as shown in
FIG. 14 . The electrospinning process was conducted at an extrusion speed of 2 mL/hr, a voltage of 42 kV, and a distance from the needle to the collecting board of 25 cm. The needle was negatively charged and the collecting board was positively charged. The diameter of the ultrafine fibers around 2 μm. - Ex. 10: Morphology of 3D Electrospun Scaffold from Wheat Gliadin
- Wheat gliadin (25 wt %), a prolamin in wheat, and 25 wt % of SDS were dissolved in water and electrospun into 3D structures as shown in
FIG. 15 . The electrospinning process was conducted at an extrusion speed of 2 mL/hr, a voltage of 42 kV, and a distance from the needle to the collecting board of 25 cm. The needle was negatively charged and the collecting board was positively charged. The diameter of fibers in 3D gliadin electrospun scaffold ranged from 1.5 to 3.5 μm. - Ex. 11: Morphology of 3D Electrospun Scaffold from Casein
- Casein (25 wt %), the family of proteins commonly found in mammalian milk, and 25 wt % of SDS were dissolved in water and electrospun into 3D structures as shown in
FIG. 16 . The electrospinning process was conducted at an extrusion speed of 2 mL/hr, a voltage of 42 kV, and a distance from the needle to the collecting board of 25 cm. The needle was negatively charged and the collecting board was positively charged. The diameter of fibers in 3D casein electrospun scaffold ranged from 0.8 to 2.8 μm. - Ex. 12: Morphology of 3D Electrospun Scaffold from Peanut Protein
- Peanut protein (25 wt %) and 25 wt % of SDS were dissolved in water and electrospun into 3D structures as shown in
FIG. 17 . The electrospinning process was conducted at an extrusion speed of 2 mL/hr, a voltage of 42 kV, and a distance from the needle to the collecting board of 25 cm. The needle was negatively charged and the collecting board was positively charged. The diameter of fibers in 3D peanut protein electrospun scaffold ranged from 0.9 to 2.9 μm. - Relationship between Specific Pore Volume and Surface Resistivity
- A power function was used to simulate the relationship between the specific pore volume of electrospun scaffolds and corresponding polymer surface resistivity. As shown in
FIG. 18 a, the residual standard error of the model is 0.613, which is a reasonable number to indicate that the data could be well described by power function and suggests that there is a strong quantitative relationship between the specific pore volume and surface resistivity. The power function was constructed as y=axb where y represented specific pore volume, x represented surface resistivity, and a and b were coefficients varied with the type of materials. Here, for PEG, a equaled to 2.208×105 and b equaled to −0.5325. The specific pore volume decreased exponentially as surface resistivity increased. As surface resistivity decreased from 109 to 106 Ω/sq., the macrostructure of PEG scaffolds converted from 3D to 2D, and the specific pore volume decreased by about 20 times. It may be inferred that the increased surface conductivity increased fluffiness of scaffolds exponentially. It was found that surface resistivity of the polymer decreased with increasing SDS proportion. As shown inFIG. 18 b, surface resistivity of PEG decreased as SDS content increased. Surface resistivity of pure PEG was higher than 109 Ω/sq. When the weight ratio of SDS to PEG was increased to 1:1, surface resistivity was reduced considerably to 106 Ω/sq. However, when NaCl was added into the polymer, the surface resistivity did not decrease as substantially as the same mole of SDS was added. This is because when water evaporated, SDS mainly distributed on the surface of polymer while NaCl may distribute more evenly in the polymer. The sulfate groups of SDS that concentrated on the surface of fiber oriented toward the outside and could induce formation of a surface water layer on the fibers. In the surface water layer of PEG fibers, free movement of dissociable sodium ions from SDS effectively decreased surface resistivity of PEG electrospun fibers. Whereas the evenly distributed NaCl would only decrease the volume resistivity but could not effectively decrease surface resistivity of fibers. In summary, by adding SDS, the polymer was converted from insulator to semiconductor, the capability of transferring static electricity of the fiber has been tremendously increased, and this correspondingly increased the fluffiness of scaffolds. - To further investigate the effect of electron transference on formation of 3D architectures, a solution with 25 wt % zein and 25 wt % SDS was electrospun onto the positively charged collecting board covered by a layer of insulator. Delivery of electrons was interrupted though positive potential still existed. Zein fibers with electrons on the surface were attracted by the positive collector and then hit the board vertically as shown in
FIG. 19 a. However, the electrons could not be transferred onto the collecting board and thus remained on the fibers. The highly negatively charged fibers attached onto the insulator tightly, owing to the strong electrical attraction, and consequently a traditional 2D electrospinning scaffold (FIGS. 19 b and c) was formed. - Having illustrated and described the principles of the present invention, it should be apparent to persons skilled in the art that the invention can be modified in arrangement and detail without departing from such principles.
- Although the materials and methods of this invention have been described in terms of various embodiments and illustrative examples, it will be apparent to those of skill in the art that variations can be applied to the materials and methods described herein without departing from the concept, spirit and scope of the invention. All such similar substitutes and modifications apparent to those skilled in the art are deemed to be within the spirit, scope and concept of the invention as defined by the appended claims.
Claims (20)
1. A method of making a randomly-oriented 3-D fibrous structure, the method comprising electrospinning a spinning dope with an electrospinning apparatus, wherein the spinning dope comprises:
a solvent;
a polymer dissolved in the solvent, wherein the dissolved polymer is in subunits having molecular weights that are about 5 to about 150 kDa; and
a surfactant;
to form one or more fibers that comprise a polymer-surfactant complex and that arrange randomly and evenly in three dimensions when contacting a collecting board of the electrospinning apparatus thereby forming the randomly-oriented 3-D fibrous structure.
2. The method of claim 1 , wherein the polymer is selected from the group consisting of protein, synthetic polymer, and combinations thereof.
3. The method of claim of claim 2 , wherein the protein is selected from the group consisting of plant protein, animal protein, and combinations thereof.
4. The method of claim 1 , wherein the spinning dope has a concentration of the surfactant that is about 5 to about 300 percent by weight of the polymer.
5. The method of claim 1 , wherein the surfactant is selected from the group consisting of anionic surfactant, cationic surfactant, nonionic surfactant, zwitterionic surfactant, and combinations thereof.
6. The method of claim 1 , wherein the solvent is selected from the group consisting of water, phosphate buffered saline (PBS), carbonate buffer, tris-glycine buffer, borate buffer, acetate buffer, n-cyclohexyl-2-aminoethanesulfonic acid (CHES) buffer, citric buffer, ethanol, chloroform, 1,4-dioxane, methanol, ethylene glycol, acetone, ethyl acetate, methyl acetate, hexane, petrol ether, citrus terpenes, diethyl ether, dichloromethane, dimethylformamide (DMF), acetonitrile (MeCN), dimethyl sulfoxide (DMSO), formic acid, n-butanol, isopropanol (IPA), n-propanol, acetic acid, nitromethane, dichloromethane, and combinations thereof.
7. The method of claim 1 , wherein:
the fibers have a fineness that is about 50 nm to about 100 μm;
the randomly-oriented 3-D fibrous structure further comprises interconnected pores having sizes that are about 10 to 2000 μm; and
the randomly-oriented 3-D fibrous structure has a porosity that is about 60 to about 99.9% by volume.
8. The method of claim 1 , wherein:
the polymer consists of a primary polymer and one or more secondary polymers and the spinning dope further comprises a first cross-linker, a sacrificial component, or a combination thereof; or
the method further comprises contacting the fibers with a second solution that comprises a second cross-linker, a surface decorator, or a combination thereof; or
a combination thereof.
9. The method of claim 8 , wherein the first cross-linker is at a concentration of about 0.01 mol/L to about 10 mol/L of the spinning dope, and
wherein the sacrificial component is at a concentration of about 0.5% to about 50% based on the weight of the polymer, and
wherein the second solution has a concentration of the second cross-linker that is about 0.01 mol/L to about 10 mol/L, and
wherein the surface decorator is at concentration of about 0.5% to about 10% based on the weight of the polymer.
10. The method of claim 9 , wherein the first and second cross-linkers are independently selected from the group consisting of polycarboxylic acid which contains at least three carboxylic acid groups, oxysucrose, genepin, glutaraldehyde, oxaldehyde, NHS esters, maleimides, carbodiimide, isocyanate, and combinations thereof, and
wherein the sacrificial component is selected from the group consisting of PEG, egg white protein, zein, wheat gliadin, and combinations thereof, and
wherein the surface decorator is one or more peptides selected from the group consisting of Arg-Gly-Asp (RGD), Ile-Lys-Val-Ala-Val (IKVAV), and Asn-Ser-Gly-Ala-Ile-Thr-Ile-Gly (NSGAITIG).
11. The method of claim 1 , wherein the polymer is a protein and the method further comprises aging the dissolved protein at an aging temperature that is about 20 to about 90° C. for an aging duration that is about 0.5 to about 48 hours before conducting the electrospinning.
12. The method of claim 1 , further comprising contacting the fibers with a coagulation solution that comprises a coagulant to modify the water stability and mechanical properties of the fibers.
13. The method of claim 12 , wherein the coagulant is selected from the group consisting of methanol, ethanol, sodium sulfate and acetic acid, acetone, sulfuric acid, hydrochloric acid, and combinations thereof.
14. A method of making a randomly-oriented 3-D fibrous structure, the method comprising electrospinning a spinning dope with an electrospinning apparatus, wherein the spinning dope comprises:
a solvent;
a polymer dissolved in the solvent, wherein the dissolved polymer is in subunits having molecular weights that are about 10 to about 50 kDa, and wherein the polymer is selected from the group consisting of protein, synthetic polymer, and combinations thereof; and
an anionic surfactant at about 5 to about 300 percent by weight of the polymer;
to form one or more fibers of a fineness that is about 50 nm to about 100 μm and that comprise a polymer-surfactant complex and that arrange randomly and evenly in three dimensions when contacting a collecting board of the electrospinning apparatus thereby forming the randomly-oriented 3-D fibrous structure that further comprises interconnected pores having sizes that are about 10 to 2000 μm and that has a porosity that is about 60 to about 99.9% by volume.
15. A randomly-oriented 3-D fibrous structure comprising:
one or more fibers that comprise a polymer-surfactant complex, wherein the fiber(s) have lengths that are at least about 100 nm and finenesses that are about 50 nm to about 100 μm, and are arranged randomly and evenly in three dimensions throughout the randomly-oriented 3-D fibrous structure; and
interconnected pores having sizes that are about 10 to 2,000 μm, wherein the pores comprise about 60 to about 99.9% by volume of the randomly-oriented 3-D fibrous structure.
16. The randomly-oriented 3-D fibrous structure of claim 15 , wherein:
the fineness of the one or more fibers is about 50 nm to about 20 μm; and
the interconnected pores have sizes that are about 100 to 1,000 μm, wherein the pores comprise about 90 to about 99.9% by volume of the randomly-oriented 3-D fibrous structure.
17. The randomly-oriented 3-D fibrous structure of claim 15 , wherein the polymer-surfactant complex is formed via electrospinning of a spinning dope that comprises a solvent; a polymer dissolved in the solvent, wherein the dissolved polymer is in subunits having molecular weights that are about 5 to about 150 kDa; and a surfactant.
18. The randomly-oriented 3-D fibrous structure of claim 17 , wherein the surfactant is selected from the group consisting of anionic surfactant, cationic surfactant, nonionic surfactant, zwitterionic surfactant, and combinations thereof; and wherein the polymer is selected from the group consisting of protein, synthetic polymer, and combinations thereof.
19. The randomly-oriented 3-D fibrous structure of claim 18 , wherein the protein is selected from the group consisting of plant protein, animal protein, and combinations thereof.
20. The randomly-oriented 3-D fibrous structure of claim 19 , wherein:
the plant protein is selected from the group consisting of wheat gluten, wheat gliadin, wheat glutenin, soy protein, camelina protein, peanut protein, canola protein, sorghum protein, rice protein, millet protein, sunflower seed protein, pumpkin seed protein, mung bean protein, red bean protein, chickpea protein, green pea protein, and combinations thereof;
the animal protein is selected from chicken feather, egg white, wool keratin, casein, silk, fibrin, collagen, gelatin, hair keratin, horn keratin, nail keratin, whey protein, and combinations thereof; and
the synthetic polymer is selected from the group consisting of polyethylene glycol (PEG), poly lactic acid (PLA), poly glycolic acid (PGA), polyhydroxyalkanoates (PHAs), poly(lactic-co-glycolic acid) (PLGA), poly-3-hydroxybutyrate (PHB), polyhydroxyvalerate (PHV), polyhydroxyhexanoate (PHH), poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV), and combinations thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/935,721 US20140011416A1 (en) | 2012-07-05 | 2013-07-05 | Three Dimensionally and Randomly Oriented Fibrous Structures |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261668269P | 2012-07-05 | 2012-07-05 | |
| US13/935,721 US20140011416A1 (en) | 2012-07-05 | 2013-07-05 | Three Dimensionally and Randomly Oriented Fibrous Structures |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20140011416A1 true US20140011416A1 (en) | 2014-01-09 |
Family
ID=49878861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US13/935,721 Abandoned US20140011416A1 (en) | 2012-07-05 | 2013-07-05 | Three Dimensionally and Randomly Oriented Fibrous Structures |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US20140011416A1 (en) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108728395A (en) * | 2017-04-17 | 2018-11-02 | 苏州工业园区新国大研究院 | It is used to prepare the method and device of the three dimensional biological holder with gradual change type spiral composite construction |
| CN109457318A (en) * | 2018-11-14 | 2019-03-12 | 东华大学 | A kind of preparation method of three-dimensional random orientation fiber |
| WO2019084209A1 (en) | 2017-10-24 | 2019-05-02 | Embody Llc | Biopolymer scaffold implants and methods for their production |
| CN110615834A (en) * | 2019-10-30 | 2019-12-27 | 天津市农作物研究所(天津市水稻研究所) | Single prolamin extraction method capable of meeting purity identification requirement of millet hybrid |
| US10617787B2 (en) | 2017-05-16 | 2020-04-14 | Embody Inc. | Biopolymer compositions, scaffolds and devices |
| CN111826728A (en) * | 2020-07-03 | 2020-10-27 | 东华大学 | A self-crimping electrospun micro-nanofiber with wool fiber as receiving substrate |
| CN112322051A (en) * | 2020-11-24 | 2021-02-05 | 中国科学院过程工程研究所 | Composite protein and preparation method and application thereof |
| CN112481737A (en) * | 2020-11-24 | 2021-03-12 | 中国科学院过程工程研究所 | Composite protein fiber and preparation method and application thereof |
| US11020509B2 (en) | 2019-02-01 | 2021-06-01 | Embody, Inc. | Microfluidic extrusion |
| CN113913360A (en) * | 2020-07-07 | 2022-01-11 | 诺一迈尔(苏州)生命科技有限公司 | Fibrous membrane for in vitro cell culture |
| CN117802696A (en) * | 2024-03-01 | 2024-04-02 | 中国农业大学 | Zein nanofiber membrane and preparation method thereof |
| US12290612B2 (en) | 2013-03-14 | 2025-05-06 | Lifenet Health | Aligned fiber and method of use thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090081457A1 (en) * | 2007-01-22 | 2009-03-26 | Ramanathan Nagarajan | Polymer-micelle complex as an aid to electrospinning |
| US20090261035A1 (en) * | 2006-09-20 | 2009-10-22 | E. I. Du Pont De Nemours And Company | Nanowebs |
| US20100129450A1 (en) * | 2005-03-11 | 2010-05-27 | Wake Forest University Health Sciences | Electrospun Cell Matrices |
| US20110020917A1 (en) * | 2007-06-22 | 2011-01-27 | Innovative Surface Technologies, Inc. | Nanofibers containing latent reactive groups |
-
2013
- 2013-07-05 US US13/935,721 patent/US20140011416A1/en not_active Abandoned
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100129450A1 (en) * | 2005-03-11 | 2010-05-27 | Wake Forest University Health Sciences | Electrospun Cell Matrices |
| US20090261035A1 (en) * | 2006-09-20 | 2009-10-22 | E. I. Du Pont De Nemours And Company | Nanowebs |
| US20090081457A1 (en) * | 2007-01-22 | 2009-03-26 | Ramanathan Nagarajan | Polymer-micelle complex as an aid to electrospinning |
| US20110020917A1 (en) * | 2007-06-22 | 2011-01-27 | Innovative Surface Technologies, Inc. | Nanofibers containing latent reactive groups |
Cited By (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12290612B2 (en) | 2013-03-14 | 2025-05-06 | Lifenet Health | Aligned fiber and method of use thereof |
| CN108728395A (en) * | 2017-04-17 | 2018-11-02 | 苏州工业园区新国大研究院 | It is used to prepare the method and device of the three dimensional biological holder with gradual change type spiral composite construction |
| US12491287B2 (en) | 2017-05-16 | 2025-12-09 | Embody, Inc. | Biopolymer compositions, scaffolds and devices |
| US10617787B2 (en) | 2017-05-16 | 2020-04-14 | Embody Inc. | Biopolymer compositions, scaffolds and devices |
| US10835639B1 (en) | 2017-05-16 | 2020-11-17 | Embody Inc. | Biopolymer compositions, scaffolds and devices |
| US11331410B2 (en) | 2017-05-16 | 2022-05-17 | Embody, Inc. | Biopolymer compositions, scaffolds and devices |
| US11116870B2 (en) | 2017-05-16 | 2021-09-14 | Embody Inc. | Biopolymer compositions, scaffolds and devices |
| US11213610B2 (en) | 2017-10-24 | 2022-01-04 | Embody Inc. | Biopolymer scaffold implants and methods for their production |
| WO2019084209A1 (en) | 2017-10-24 | 2019-05-02 | Embody Llc | Biopolymer scaffold implants and methods for their production |
| US10653817B2 (en) | 2017-10-24 | 2020-05-19 | Embody Inc. | Method for producing an implantable ligament and tendon repair device |
| US12201748B2 (en) | 2017-10-24 | 2025-01-21 | Embody, Inc. | Biopolymer scaffold implants and methods for their production |
| CN109457318A (en) * | 2018-11-14 | 2019-03-12 | 东华大学 | A kind of preparation method of three-dimensional random orientation fiber |
| US11020509B2 (en) | 2019-02-01 | 2021-06-01 | Embody, Inc. | Microfluidic extrusion |
| US11338057B2 (en) | 2019-02-01 | 2022-05-24 | Embody, LLC | Microfluidic extrusion |
| US11338056B2 (en) | 2019-02-01 | 2022-05-24 | Embody, Inc. | Microfluidic extrusion |
| US12233185B2 (en) | 2019-02-01 | 2025-02-25 | Embody, Inc. | Microfluidic extrusion |
| CN110615834A (en) * | 2019-10-30 | 2019-12-27 | 天津市农作物研究所(天津市水稻研究所) | Single prolamin extraction method capable of meeting purity identification requirement of millet hybrid |
| CN111826728A (en) * | 2020-07-03 | 2020-10-27 | 东华大学 | A self-crimping electrospun micro-nanofiber with wool fiber as receiving substrate |
| CN113913360A (en) * | 2020-07-07 | 2022-01-11 | 诺一迈尔(苏州)生命科技有限公司 | Fibrous membrane for in vitro cell culture |
| CN112481737A (en) * | 2020-11-24 | 2021-03-12 | 中国科学院过程工程研究所 | Composite protein fiber and preparation method and application thereof |
| CN112322051A (en) * | 2020-11-24 | 2021-02-05 | 中国科学院过程工程研究所 | Composite protein and preparation method and application thereof |
| CN117802696A (en) * | 2024-03-01 | 2024-04-02 | 中国农业大学 | Zein nanofiber membrane and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20140011416A1 (en) | Three Dimensionally and Randomly Oriented Fibrous Structures | |
| Antinori et al. | Advanced mycelium materials as potential self-growing biomedical scaffolds | |
| Zong et al. | Electrospun fine-textured scaffolds for heart tissue constructs | |
| Torres-Giner et al. | Characterization of the morphology and thermal properties of zein prolamine nanostructures obtained by electrospinning | |
| Kim et al. | Macroporous and nanofibrous hyaluronic acid/collagen hybrid scaffold fabricated by concurrent electrospinning and deposition/leaching of salt particles | |
| Huang et al. | Biomimetic LBL structured nanofibrous matrices assembled by chitosan/collagen for promoting wound healing | |
| Wang et al. | Differences in cytocompatibility between collagen, gelatin and keratin | |
| Tedesco et al. | Soft chitosan microbeads scaffold for 3D functional neuronal networks | |
| Saudi et al. | Nanonet-nano fiber electrospun mesh of PCL–chitosan for controlled and extended release of diclofenac sodium | |
| Hong et al. | Electroactive bio-composite actuators based on cellulose acetate nanofibers with specially chopped polyaniline nanoparticles through electrospinning | |
| Alessandrino et al. | Electrospun silk fibroin mats for tissue engineering | |
| Cao et al. | Continuous high-content keratin fibers with balanced properties derived from wool waste | |
| An et al. | Preparation of fish gelatin and fish gelatin/poly (l-lactide) nanofibers by electrospinning | |
| Wu et al. | Crimped fiber with controllable patterns fabricated via electrohydrodynamic jet printing | |
| Shan et al. | Electrospinning of chitosan/poly (lactic acid) nanofibers: the favorable effect of nonionic surfactant | |
| Goyal et al. | Development of hybrid scaffolds with natural extracellular matrix deposited within synthetic polymeric fibers | |
| Shahmoradi et al. | Controlled surface morphology and hydrophilicity of polycaprolactone toward human retinal pigment epithelium cells | |
| US11643444B2 (en) | Silk nanofibrils and uses thereof | |
| Pant et al. | Electrospun gelatin/nylon‐6 composite nanofibers for biomedical applications | |
| Prado-Prone et al. | Single-step, acid-based fabrication of homogeneous gelatin-polycaprolactone fibrillar scaffolds intended for skin tissue engineering | |
| Lari et al. | PEDOT: PSS‐containing nanohydroxyapatite/chitosan conductive bionanocomposite scaffold: fabrication and evaluation | |
| Basbug et al. | Exploring Waste Wool Derived-Keratin Nanofiber Architectures on Cotton Fabrics: Electrospinning Strategies for Enhanced Material Properties | |
| Karahaliloğlu | Cell-compatible PHB/silk fibroin composite nanofibermat for tissue engineering applications | |
| Feng et al. | Novel shish-kebab structured nanofibrous decorating chitosan unidirectional scaffolds to mimic extracellular matrix for tissue engineering | |
| Mazoochi et al. | Chitosan nanofibrous scaffold fabricated via electrospinning: the effect of processing parameters on the nanofiber morphology |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA, NE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:YANG, YIQI;XU, HELAN;CAI, SHAOBO;SIGNING DATES FROM 20130917 TO 20130918;REEL/FRAME:031297/0011 |
|
| AS | Assignment |
Owner name: NUTECH VENTURES, NEBRASKA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA;REEL/FRAME:041101/0357 Effective date: 20170113 |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |